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ABSTRACT
This synthesis report is part of the gender and noncommunicable diseases (NCDs) initiative launched by the WHO Regional Office for 
Europe, which aims to strengthen the response to NCDs through a gender approach. It is part of a series that includes country profiles with a 
gender analysis of the WHO STEPwise Survey (STEPS) data for each country. This report presents an analysis of the first eight country profiles 
to support international commitments to reducing the burden of NCDs with evidence and knowledge exchange. A gender analysis of 
STEPS NCD risk-factor survey data describes how risk factors for chronic diseases differ between and among men and women by exploring 
and tracking the direction and magnitude of trends and exposure to risk factors and accessing services by sociodemographic variables. 
Important differences hide even in sex-disaggregated data that need to be unpacked through sociodemographic characteristics, because 
men and women are not homogenous groups. The report also recognizes gaps in evidence and calls for further analysis of the impact of 
gender-based inequalities.
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Non-communicable diseases (NCDs) represent the main burden of disease in Europe. Access to and use of 
services, exposure to risk factors, and morbidity and mortality differ based on gender. These differences are 
also present between groups of men and women depending on where they live, what they do, how old they 
are and a range of other sociodemographic and cultural factors that influence exposure to risk and access to 
services. 
There is a greater than four-fold difference for men and five-fold for women in premature deaths due to NCDs 
across countries in our Region. While cancer, cardiovascular diseases, diabetes and other NCDs are the main 
cause of ill health for both men and women, men are nearly twice as likely to die prematurely from NCDs. Men’s 
higher risk of dying earlier, mostly to cardiovascular disease, should be at the centre of countries’ efforts to 
reduce premature mortality from NCDs. We also cannot disregard the fact that cardiovascular disease remains 
the main cause of death for women. Research, treatment, and health promotion and prevention efforts often 
present a gender bias that ignores this reality. 
Behaviours are influenced by gender norms, roles and relations that affect exposure to risk factors and health- 
and help-seeking behaviours. Our interactions with the health system, including treatment adherence and 
outcomes, also vary based on gender.
If we want to accelerate progress and truly leave no one behind in our efforts to reduce the burden of NCDs, 
we cannot be gender-blind. 
This report is the first gender and NCD analysis using data collected through the STEPwise approach to Surveillance 
(STEPS) surveys in our Region.  Used in over 100 countries worldwide, STEPS surveys provide an important tool 
for collecting information on behavioural and biological risk factors for NCDs and health system responses. This 
project highlights the importance of systematic data collection at national level with vital disaggregation by age, 
sex and variables such as education and place of residence.
This is a decisive piece of work that will inform policy design and gender-responsive action to reduce the burden 
of NCDs in the WHO European Region. The findings demonstrate concerning differences across the life-course. 
We cannot ignore that the percentage of men in younger age groups with multiple risk factors is double that 
of females. The increase of risk, however, is much faster for women in older age groups, who have 3–11 times 
higher multiple risk factors. 
The report reveals important challenges that need to be addressed. Although great progress has been made, 
we must acknowledge the impact of widespread inequalities and group-specific risks, shortfalls and gender 
biases if we are to strengthen prevention and management of NCDs. Gender-responsive actions are needed 
urgently if we are adequately to prevent, detect, manage and control NCDs now and for future generations. 
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This necessary gender-responsive approach is operationalized in the WHO European Programme of Work, our 
agenda for health 2020–2025, United action for better health. The agenda mobilizes action to leave no one 
behind, including by identifying those groups of women and men who are more difficult to reach through 
effective policies and interventions. I am convinced that the enhanced country focus within the Programme 
of Work will mean these findings will be used to accelerate the NCD response, from prevention to care, and 
support gender-responsive health systems across our Region. The WHO Regional Office for Europe stands ready 
to support.  
Hans Henri P. Kluge
WHO Regional Director for Europe
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This report is part of a series developed by the WHO Regional Office for Europe within a collaboration 
between the Gender and Human Rights programme and the WHO European Office for the 
Prevention and Control of Noncommunicable Diseases to accelerate progress towards reducing the 
burden of noncommunicable diseases using a gender approach. 
The editors of the series and of this report are Isabel Yordi Aguirre and Ivo Rakovac from the WHO 
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This report presents an analysis of sex-disaggregated data gathered through the WHO STEPwise 
(STEPS) survey in the first eight countries of a series developed by the WHO Regional Office for 
Europe as part of an interprogrammatic initiative on gender and noncommunicable diseases (NCDs) 
to improve the response to NCDs in the WHO European Region. The report is a synthesis of the 
analysis of data in Armenia, Belarus, Georgia, Kyrgyzstan, the Republic of Moldova, Turkey, Ukraine 
and Uzbekistan. The findings make an important contribution to, and serve as an evidence base 
for, international commitments on NCDs in accelerating action towards reducing the NCD burden 
and ensuring universal health coverage. They also contribute to raising awareness and building 
capacity among country-based researchers and policy-makers on the rationale for applying a 
gender analysis to health data.
A gender analysis of STEPS NCD risk-factor survey data describes how risk factors for chronic 
diseases differ between and among men and women by exploring and tracking the direction and 
magnitude of trends in exposure to risk factors and accessing services. This analysis enables better 
planning and/or evaluation of gender-responsive health promotion or preventive campaigns and 
gender-responsive interventions. 
As sex-disaggregated data can hide important differences among men or women, the analysis also 
explores within-group differences by including sociodemographic characteristics such as age group, 
geographic location, education, employment and income level across countries. 
Findings represent observed common trends and differences, while data presented in the report 
also show variance by country. Key findings across countries include the following.
• Significantly higher percentages of men than women in most age groups engage in 
behavioural risk factors for NCDs (like tobacco-smoking, alcohol consumption, insufficient 
levels of physical activity, insufficient intake of fruit and vegetables, adding salt and 
frequent consumption of processed foods). 
• Significantly higher percentages of women than men in the older age groups are found 
with most of the biological risk factors (overweight and obesity, and raised blood pressure, 
glucose and cholesterol levels), while the rate is often lower among women than men in 
the younger age groups. 
• While the percentage of men with multiple risk factors typically doubles from the youngest 
to the oldest age group, the percentage of women with multiple risk factors is more often 
between three to 11 times greater in the oldest than the youngest age group.
• An analysis of behavioural and biological risk factors by geographic location further shows 
risk factors for men and women are not the same within urban and rural settings. 
• Prevalence of behavioural risk factors are more often higher for urban women, and 
prevalence of biological risk factors are more often higher for women in rural areas. 
Differences are observed for men, but it varies by country, with no clear trend across 
countries. 
• Prevalence of behavioural risk factors for men and women varies by education level, with 
the prevalence of risk factors higher among low-education groups and lower among high-
EXECUTIVE SUMMARY
viii
education groups. The trend for biological risk factors is more consistent, with prevalence typically 
higher for high-education men and low-education women than for other levels, but it varies by 
country. The differences in prevalence between education levels tends to be greater for women 
than men.
• More high-income and employed men and women engage in behavioural risk factors, while low 
incomes and unemployment are linked with higher prevalence of biological risk factors for men 
and (especially) women.
• The importance of further examining risk factors within groups of men and women is exemplified 
by country examples of migrant men and women having higher prevalence of multiple NCD risk 
factors than the greater population, higher prevalence of biological factors for men and women 
currently living with a partner than those living without, and specific behavioural risk factors 
being higher or lower in prevalence among ethnic minority men and women than the majority, 
depending on the context. 
• In some areas, there are gaps between exposure to risk and response from health services. For 
example, in most countries higher percentages of men than women have not been measured for 
biological risk factors and lower percentages of men than women have been given lifestyle advice 
by a health-care professional on most behavioural risk factors. 
• Compared to urban areas, more men and women in rural areas have not been measured for risk 
factors, with rural women often being tested more than men in rural and urban areas. 
• Women and men in the low education level groups are being measured for risk factors less than 
those in the high education level groups. 
• More men and women in the low-income and unemployed groups or who are not in the labour 
force have not been measured for risk factors compared to employed and high-income groups. 
• Improving access to services for women and men may require that additional attention is paid to 
specific groups, including the following: men and women in rural areas, men and women in the 
low education level, low-income and unemployed groups or those not in the labour force, migrant 
men and women, and some ethnic minority groups.
Globally, more than 100 countries have collected data through the STEPS surveys, but this series is the 
first time a more in-depth analysis from a gender perspective has been conducted. The results of this 
analysis can be used as evidence for addressing needs among specific populations and informing policies 
in countries in the Region. It can also serve as an analysis model for countries using the WHO STEPwise 
Survey in other regions.
Studies that specifically examine gender and social norms and gender inequality in these contexts can be 
used to complement this analysis by identifying driving and constraining factors for men and women in 
exposure to risk, access to services and interactions with health-care and other professionals in services.
In addressing the areas identified in this report, cost-effective interventions like best-buy and other 
interventions recommended by WHO should be prioritized and tailored to the country-specific context to 
ensure uptake and efficiency. This would greatly contribute to the implementation of the WHO European 
Programme of Work and achievement of universal health coverage and the health-related Sustainable 
Development Goals.
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The WHO Regional Office for Europe launched a gender and noncommunicable diseases (NCDs) initiative in 
2019 to improve the response to NCDs in the WHO European Region through a gender approach. Gender 
and rights-based approaches are imperative to accelerate transformative and sustainable progress towards 
achievement of the United Nations Sustainable Development Goals (SDGs). The strategies on women’s 
health and well-being (1) and the health and well-being of men in the WHO European Region (2) strengthen 
the links between SDGs 3 and 5 in the Region while providing a comprehensive working framework for 
improving health and well-being in Europe through gender-responsive approaches. 
Commitments by Member States of the WHO European Region to accelerate actions towards reducing NCDs 
build on the Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European 
Region 2016–2025 (3) and high-level meetings, in particular Health Systems Respond to NCDs: Experience 
in the European Region (Sitges, Spain, 16–18 April 2018) (4) and the WHO European High-level Conference 
on Noncommunicable Diseases: Time to Deliver – Meeting Noncommunicable Disease Targets to Achieve 
the Sustainable Development Goals in Europe (Ashgabat, Turkmenistan, 9 April 2019) (5).
To support these commitments with evidence and knowledge exchange, this synthesis report and country 
profiles of Armenia, Belarus, Georgia, Kyrgyzstan, the Republic of Moldova, Turkey, Ukraine and Uzbekistan 
have so far been created using a gender analysis of data gathered through the WHO STEPwise approach to 
Surveillance (STEPS) NCD risk-factor survey. 
This synthesis report presents a combined analysis of sex-disaggregated data linked with other variables, 
such as geographic location, education, income and employment. The analysis allows identification of main 
gender-based differences and highlights some of the areas that need further gender analysis. Evidence 
generated within the synthesis report and country profiles in the series is intended to provide an evidence 
base and rationale for countries to strengthen health systems and whole-of-government responses to 
prevent, detect, manage and control NCDs, particularly at primary-care levels, through gender-responsive 
actions (Fig. 1). 
Source: WHO (6).
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Fig. 1. WHO gender-response assessment scale
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INTRODUCTION
A gender analysis approach
 
A gender analysis considers socially constructed norms, roles, behaviours and attributes that a given society 
considers appropriate for women and men and how this implies differential degrees of power between and 
among women and men. It recognizes that women and men are not homogenous groups and that their 
health opportunities and risks vary according to social, economic, environmental and cultural influences 
throughout their lifetime, while also considering how gender intersects with other factors behind social 
inequalities, such as age, employment, education, ethnicity or place of residence.
The STEPS surveys (7) gather information on NCD risk factors to help plan and evaluate programmes 
and interventions by collecting standardized, high-quality risk-factor data to enable comparisons while 
allowing flexibility. The STEPS surveys consist of interviews (STEP 1), physical measurements such as blood 
pressure, weight and height (STEP 2) and biochemical measurements like blood glucose and cholesterol 
(STEP 3). An integrated approach is used, allowing an analysis of multiple risk factors simultaneously in 
a cost-efficient manner. WHO provides countries with a reference methodology for NCD surveillance and 
technical support for implementation. 
The surveys in this analysis were carried out in participating countries from 2013 to 2019 (Table 1). A cluster 
sample design was used to produce nationally representative data for each of the countries. The data were 
weighted for complex survey design, non-response rate and population distribution by age and sex.
STEPs data reveal a vast amount of information that it is not always presented disaggregated by sex 
and may therefore mask important differences between men and women. Without intending to compare 
countries, this report aims to present key gender-based considerations across countries that can help to 
improve planning and/or evaluation of gender-responsive health promotion or preventive campaigns and 
gender-responsive interventions. 
Table 1. STEPS surveys by country
Country Year Age range Response rate (%) Participants
Armenia 2016 18–69 42.0 2 349
Belarus 2017 18–69 87.0 5 010
Georgiaa 2016 18–69 75.7 5 554
Kyrgyzstan 2013 25–64 100.0 2 623
Republic of Moldova 2013 18–69 83.5 4 807
Turkey 2017 15–70+ 70.0 6 053
Ukraine 2019 18–69 57.0 4 409
Uzbekistana 2019 18–69 88.3 4 320
a STEPS surveys have been conducted on two occasions in Georgia (2010 and 2016) and Uzbekistan (2014 and 2019). The most recent surveys were used in this report for 
 comparison with other countries.
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It is important to highlight that men and women are not homogenous groups and important gender 
issues need to be unpacked within these groups across the life-course by including sociodemographic 
characteristics. Not all countries emphasize the same variables, however, and this only reinforces the 
richness and importance of a context-driven analysis.
The analys of disaggregated data is the first step in mainstreaming gender in any health issue (6) (Fig. 2). 
Country analyses did not go into identifying the impact of gender inequalities and gender norms, roles 
and relations on different exposure to risk and access to services. This would require a more qualitative 
approach to the research.
The synthesis report is organized around the key elements identified by the WHO Regional Office for Europe 
under the Gender and Noncommunicable Diseases initiative and the WHO report Why using a gender 
approach can accelerate noncommunicable disease prevention and control in the WHO European Region (8):
1. NCDs constitute the main burden of disease for both women and men in the WHO European 
Region, but there are important differences;
2. risk factors for NCDs are strongly influenced by gender and the links with other social determinants 
of health;
3. gender impacts the way men and women use services and the responses they receive; 
4. gender inequality impacts access and use of health resources; and
5. gender stereotypes may be ignored, perpetuated or challenged by health promotion efforts  
to prevent NCDs.
Source: WHO (6).
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Fig. 2. Gender mainstreaming steps
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NCDs constitute the main burden of disease for both women and men in the 
WHO European Region, but there are important differences 
NCDs are the leading cause of mortality in the world and a large part of the disease burden in the 
WHO European Region, the region of the world most affected by NCDs. The five major NCDs (diabetes, 
cardiovascular diseases (CVDs), cancer, chronic respiratory diseases and mental disorders) account for an 
estimated 89% of all deaths and 84% of disability in the Region (9).
While a decrease in mortality from CVDs has occurred for both men and women and has contributed to 
an increase in life expectancy, CVDs are still the main contributor to the burden of disease for both men 
and women (Fig. 3 and Annex 1, Table A1.1). Though the burden of CVDs is less for women than it is for 
men, it still makes up the largest burden of disease for women by far. It is still perceived, however, as a 
men’s health issue (10). Important differences in the burden of disease are better understood through an 
examination of mortality rates and risk factors. 
DIFFERENCES IN MORTALITY RATES
The mortality rate for men is significantly higher than for women overall, and a higher increase is also 
observed from the 45–59 age group to the 60–69 age group in each of the countries. The mortality rates 
for men in the 45–59 and 60–69 age groups are two to three times the rates for women. The observable 
difference in total mortality between men and women in the 45–59 age group is even greater in the 60–69 
group (Fig. 4 and Annex 1, Table A1.2) (12). Though difficult to calculate, this difference in mortality rates 
between men and women is probably an influence on prevalence of NCD risk factors in the population 
when examining differences between men and women through the life-course. 
While NCDs affect all countries, those in the low- and middle-income categories, like the ones included in 
this analysis, feel the burden of NCDs more due to fewer resources in prevention, promotion and provision 
of care (13). The prevalence of risk factors that account for NCDs are different between and among men 
Source: Institute for Health Metrics and Evaluation (11).
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Fig. 3. Burden of disease for men and women, expressed through DALYs, 2017
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and women, however, and data show important differences in the ways men and women access health 
services that may be associated with the prevalence of NCDs.
The STEPs survey gathers data on behavioural risk factors for NCDs that are related to health behaviours, 
specifically tobacco use, harmful alcohol consumption, unhealthy diet (low fruit and vegetable consumption, 
diet high in salt and/or processed foods) and insufficient physical activity, and on biological risk factors that 
are physically or biologically measureable, specifically overweight/obesity, raised blood pressure, raised 
blood glucose and raised cholesterol. Highlighting where the differences exist between men and women 
helps to uncover where inequitable gender norms, roles, behaviours and attributes are likely to influence 
risk factors.
DIFFERENCES IN BEHAVIOURAL AND BIOLOGICAL RISK FACTORS FOR MEN AND WOMEN
The largest differences between men and women commonly are found in tobacco and alcohol use across 
countries, with smaller differences in the risk factors of unhealthy diet and physical activity. In relation to 
added salt and eating processed foods, a trend of higher prevalence among men is observed. Prevalence 
of insufficient physical activity is significantly higher for women in Kyrgyzstan, Turkey and Uzbekistan, with 
no differences in the remaining countries. More men than women engage in most of the behavioural risk 
factors, but it varies by country and risk factor (Fig. 5 and Annex 1, Table A1.3). 
  
This trend of higher prevalence among men in behavioural risk factors, with some instances of higher 
prevalence among women in insufficient physical activity, warrants further investigation into how gender 
and social norms, policies and environments may be influencing these differences in exposure and also in 
disclosure. For example, gender norms about alcohol and tobacco consumption among women may present 
response bias, as shown in differences between self-reported smoking and objectively tested cotinine (14).
The picture is different with biological risk factors, as prevalence is significantly higher for women most 
often in obesity and raised cholesterol, with some differences (although less consistently) in overweight 
and raised blood pressure. 
Prevalence of raised glucose shows no significant differences between men and women in these countries. 
The prevalence of raised blood pressure without medication, however, is the only biological risk factor 
where prevalence among men is significantly higher than among women in some countries, which may 
0 10 20 30 40 50 60 70 80 11010090
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Men
Women
60–6945–59
Fig. 4. Mortality per 1000 by age group
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reflect gender-based barriers such as norms around traditional masculinities in the uptake of services 
(Fig. 6 and Annex 1, Table A1.4). 
 
In summary, men and women are exposed to NCD risk factors differently and also are exposed to groups 
of risk factors, in this case behavioural and biological, differently. Overall across countries, men appear to 
be more exposed to behavioural risk factors, while women appear to be more exposed to biological risk, 
though differences tend to be less pronounced than some of those observed in the behavioural risk factors 
of alcohol and tobacco. These differences warrant further study of why these differences exist and how 
they can be addressed.
* Statistically significant dierence.
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DIFFERENCES ACROSS THE LIFE-COURSE
Differences between men and women are also found in simultaneous prevalence of multiple risk factors. 
In accordance with the STEPS methodology, selected risk factors were used to examine the prevalence of 
three or more risk factors in the population. These combined risk factors are:
• current daily smokers;
• fewer than five servings of fruit and vegetables per day;
• insufficient physical activity (< 150 minutes of moderate-intensity activity per week, or equivalent);
• overweight (body mass index (BMI) ≥ 25 kg/m2); and
• raised blood pressure (BP) (systolic BP ≥ 140 and/or diastolic BP ≥ 90 mmHg or currently on 
medication).
BMI: body mass index. * Statistically significant dierence.
0 10 20 30 40 50 60 70 80 10090
Overweight (BMI ≥ 25)
Obesity (BMI ≥ 30)
Raised blood pressure (or on medication)
Raised blood pressure (NOT on medication)
Raised blood glucose
Raised cholesterol
Armenia
Belarus
Georgia
Kyrgyzstan*
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia*
Belarus*
Georgia*
Kyrgyzstan*
Republic of Moldova*
Turkey*
Ukraine*
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey*
Ukraine
Uzbekistan
Armenia
Belarus*
Georgia*
Kyrgyzstan
Republic of Moldova
Turkey*
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus*
Georgia*
Kyrgyzstan*
Republic of Moldova
Turkey*
Ukraine
Uzbekistan
Men
Women
Fig. 6. Prevalence of biological risk factors with dierences between men and women (%)
More women than 
men are exposed  
to some biological 
risk factors
IMPORTANT GENDER DIFFERENCES IN NCD BURDEN
10
GENDER AND NONCOMMUNICABLE DISEASES IN EUROPE
The accumulation of multiple NCD risk factors increases by age group for both men and women. While 
more men in the younger age groups have multiple risk factors than women, however, the increase in 
multiple risk factors for women is more drastic, which leads to a lessening of the difference in percentages 
of men and women with each ascending age group. The increase for women with multiple risk factors 
between age groups therefore is greater than for men, often starting with the 45–59 age group (Fig. 7 and 
Annex 1, Table A1.5). 
These combined risk factors, however, do not include all risk factors, such as alcohol consumption or raised 
cholesterol. Additionally, risk factors have different impacts on NCD morbidity and mortality. For example, 
the risk associated with smoking is higher at individual level than the risk associated with eating fewer than 
five servings of fruit and vegetables (15): further analysis is therefore warranted to examine differences in 
these risk factors between men and women as well as among men and women.
A greater increase for women over the life-course is also observed in the analysis of specific biological risk 
factors, but not necessarily in behavioural risk factors. It is important to note that the higher mortality of 
middle-aged men in these countries, as mentioned in the previous section, may influence the fact that 
those men living to the older age groups may be living with fewer risk factors, causing less of an increase 
in prevalence of multiple risk factors for men than for women.
Important differences are hidden in prevalence of biological risk factors for men and women. In risk factors 
where prevalences for men and women are not significantly different overall, prevalence for men in the 
youngest age group is often higher than prevalence for women in the same age group. Prevalence for 
Note: age groups collected in STEPS for Kyrgyzstan are 24–34, 35–44, 45–54, 55–64 years. * Statistically significant dierence.
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women is higher than for men, however, in nearly all risk factors across countries in the oldest age group 
(Fig. 8 and Annex 1, Table A1.6). The difference in prevalence between the youngest and oldest age groups 
for women is greater than it is for men, again showing a more drastic increase in risk factors over the life-
course not only in multiple risk factors, but also in individual risk factors.  
IMPORTANT GENDER DIFFERENCES IN NCD BURDEN
a Comparable to 18–29 age group for Kyrgyzstan is 25–34 and for Turkey is 15–29. b Comparable to 60–69 age group for Kyrgyzstan is 55–64 and for Uzbekistan is 45–69.
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Risk factors for NCDs are strongly influenced by gender and the links with other 
social determinants of health 
 
An analysis of behavioural and biological risk factors by sociodemographic variables further reveals 
important differences not only between, but also among, men and women. Men and women are exposed 
to behavioural and biological risk factors differently across the sociodemographic categories of geographic 
location (urban and rural), education level, employment status and income level. Exposure to behavioural 
and biological risk factors leading to ill health can differ by socioeconomic status among men and women, 
leading to preventable health inequities linked to the social determinants of health. 
Social determinants of health refer to the conditions in which people are born, live and work that are 
influenced by factors such as their physical environment, employment status, income level, geographic 
location, access to health care, access to social networks and education (16). Stratifications often occur due 
to the interaction of a person’s social identities, including gender, age, race, ethnicity and migrant status, 
and lower socioeconomic status is often linked to more marginalized identities and their intersection, such 
as being a woman, migrant, or coming from a racial or ethnic minority community. Gender norms, roles 
and relations operate within the context of other social determinants of health to influence women’s and 
men’s access to resources (including education, financial resources and time), roles and behaviour, norms 
and values, and decision-making power and autonomy, which impact on their overall health and well-
being (17,18).
GENDER AND PLACE OF RESIDENCE
Place of residence can be used to further examine the differences in risk factors not only between, but 
also among, men and women. Data collected during the STEPS survey were designated by location and 
then categorized into urban and rural areas by country focal points (analysis by place was not included in 
the country profile for Armenia). Rural environments can affect access to health care as well as education 
and economic opportunities, especially for women. Women in rural areas are often more exposed to 
traditional stereotypes around their roles which, among other things, limits their decision-making and 
access to resources (19–21). 
Prevalence of behavioural risk factors is often higher for women in urban areas than rural, especially with 
tobacco use, alcohol consumption and insufficient physical activity. For men, no clear trend is observed 
across countries, as higher prevalence varies by country and risk factor. Prevalence of insufficient physical 
activity for men is higher in urban areas than in rural (Fig. 9 and Annex 1, Table A1.7). Prevalence of 
risk factors related to diet among men and women varies by country and geographic location, with few 
significant differences. Factors influencing the differences between urban and rural living may be similar 
for men and women in relation to their physical activity, but variance by country indicates other factors 
related to gender are likely to be present.
 
Prevalence of biological risk factors for men and women in rural areas generally is higher than in urban, but 
differences between urban and rural women are often greater than they are for men. This trend is most 
prominent with risk factors related to weight and raised blood pressure. 
GENDER AND NONCOMMUNICABLE DISEASES IN EUROPE
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These sociodemographic factors can also have different associations for men and women in biological 
risk factors. The analysis showed that with overweight and obesity, for example, the association can be 
the opposite for men and women in Belarus, Georgia and the Republic of Moldova. This difference by 
geographic location is hidden in the prevalence of overall overweight and obesity for men and women. In 
most of these countries, there are no significant differences in prevalence of overweight overall between 
men and women (Fig. 10 and Annex 1, Table A1.8). 
   
Examining prevalence among men and among women also reveals similarities across subgroups. For 
example, while prevalence of raised blood pressure (not on medication) is significantly higher among men 
* Statistically significant dierence.
0 10 20 30 40 50 60 70 80 10090
Current tobacco use
Alcohol consumption
Alcohol (heavy episodic drinking)
Unhealthy diet ( < 5 fruit/veg per day)
Unhealthy diet (add salt)
Unhealthy diet (processed food)
Insucient physical activity 
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Armenia
Belarus
Georgia
Kyrgyzstan
Republic of Moldova
Turkey
Ukraine
Uzbekistan
Men
Women
RuralUrban
Fig. 9. Prevalence of behavioural risk factors with di erences between rural and urban areas (%)
Prevalence for 
women is higher in 
urban areas; for men, 
it varies by country 
and risk factor
16
GENDER AND NONCOMMUNICABLE DISEASES IN EUROPE
than women overall in countries such as Belarus and Georgia, by geographic location it can be seen that 
prevalences for urban men and rural women are not different. As disaggregation by sociodemographic 
variables shows, important differences between men and women are hiding in the aggregated percentages 
of risk factors. 
GENDER AND EDUCATION
All eight countries have extremely high literacy rates for both men and women, and enrolment in primary 
and secondary education is also high. A significant difference occurs at tertiary level, with the percentage 
of women enrolled on average 26% higher than that for men (22). Data on education level, determined 
by the highest level of education completed, were collected in the STEPS survey using country-specific 
categories. These categories were matched to the levels of the International Standard Classification of 
Education (ISCED) (23) for each country and then condensed to reflect the three levels of low, medium and 
high in the country profiles (Annex 1, Table A1.9). To identify trends across countries, an analysis of the 
levels of high and low was conducted for this report. 
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An examination of exposure to risk factors for men and women by education levels highlighted differences 
among men and among women, but it also revealed how these differences vary across risk factors. For 
example, prevalence of tobacco use by education level follows a different pattern than prevalence of 
alcohol consumption. Prevalence of tobacco is higher in most countries among low-education men, but 
for women, it varies. Differences between high- and low-education men vary by country, with Ukraine 
having a high percentage difference and Georgia showing very little difference. With alcohol consumption, 
however, prevalence is more often higher for high-education men and women, but it again varies by 
country (Fig. 11 and Annex 1, Table A1.10). Low-education men and women tend to add salt to their diet 
more often, but the differences are less pronounced with the other risk factors related to unhealthy diet 
and are not as consistent across countries. Prevalence of risk factors among women tends to decrease with 
higher education, while there is no difference for men.
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Men and women in different education levels are also exposed to biological risk factors differently. While 
prevalence tends to be higher for women in the low education level, prevalence is often higher for men 
in the high education level. The differences are greater, however, between women in the high and low 
education groups than between high- and low-education men, especially with risk factors related to 
weight and blood pressure (Fig. 12 and Annex 1, Table A1.11). 
  
Additional differences in biological risk factors are observed when comparing education levels between 
men and women. While there are no significant differences overall between men and women in the 
overweight category for most countries, an analysis by education level shows prevalence among low-
education women is not only significantly higher than for high-education women, but in many cases is 
also higher than for low-education men (with the exception of Uzbekistan). With obesity and raised blood 
pressure, the differences between low- and high-education women more often are greater than they 
are for low- and high-education men, with higher prevalence for low-education women than for high-
education women and men of any education level. The association between gender and education level in 
relation to biological risk factors is different for women and men.
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GENDER AND EMPLOYMENT/INCOME
The employment challenges men and women face, particularly in rural areas, can lead to labour migration, 
predominantly of men. This also affects women, who are left with more economic distress and limited 
resources (24). Women’s participation in the labour force across the countries ranges from slightly less than 
men in Belarus (80.4% of men, 74.7% of women) to less than half that of men in Turkey (78.1% of men, 
37.5% of women). The estimated average annual earned income per capita for women across countries 
is approximately 55.6% of that for men. On average, approximately twice as many women than men are 
part-time workers, but the amount of hours women spend in unpaid work per day is on average from two 
to five times that of men (22). 
Both employment and income data were collected in the STEPS survey, and preference of which variable 
was to be included in the analysis of their country profile was chosen by STEPS country focal points. 
Armenia, Kyrgyzstan and Turkey included analysis by income level only, while Belarus and Georgia chose 
only employment status, given the low response rate for income in their data. The Republic of Moldova 
and Ukraine chose to include both employment status and income level in the analysis of their STEPS data. 
Five income quintiles were used in the STEPS survey and, based on average income levels and adjusting 
for household size, categories of high and low income were created. The employment status categories 
were also condensed for analysis into employed (government employee, nongovernment employee, 
self-employed) and unemployed or not in the labour force (unemployed (able or unable to work), 
student, retired).
Prevalence of tobacco use, eating processed foods and taking part in insufficient physical activity more 
often is higher among high-income men and women than low-income, but the association varies by 
country and is not the same for men and women. Prevalence varies by income level in each of the other 
behavioural risk factors. For example, prevalence of heavy episodic drinking is not significantly different for 
men and women by income level, except for men in Ukraine, where prevalence among low-income men is 
significantly higher than among high-income men (Fig. 13 and Annex 1, Table A1.12). 
  
More employed men and women are observed to engage in most behavioural risk factors than those who 
are unemployed or not in the labour force, and more significant differences are observed by employment 
status than by income level. The association again varies by country and is not the same for men and 
women (Fig. 14 and Annex 1, Table A1.13). 
Where variance between income level and employment status occurs, a closer look at the risk factor and 
country is necessary. For example, alcohol consumption shows little variance in the countries analysed by 
income level, but significant differences are shown in the countries analysed by employment status. Given 
that more variance is observed in countries analysed by employment status rather than income level, an 
analysis by employment status may be more informative moving forward. The measurement of income 
level could also be strengthened to perhaps reveal further differences. Lower response rates for income are 
common across the countries, and income may be more influenced by a response bias than employment. 
Variance of the prevalence of risk factors seen by age group may also contribute to differences in variance 
between income level and employement status, such as retired people being in the unemployed or not in 
the labour force category.
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Prevalences of most biological factors are higher for low-income women, but they vary for men. The 
differences between high and low income more often are greater for women than for men (Fig. 15 and 
Annex 1, Table A1.14). For example, prevalence of raised blood pressure is higher for low-income women 
across the countries, but for men, it varies. 
With income level, it can be seen that the association between sex and a sociodemographic variable can 
sometimes be the opposite for men and women. In this case, prevalence is more often higher for low-
income women and high-income men in Ukraine. Sociodemographic factors can be associated with risk 
factors in different ways for men and women. 
  
Prevalence of biological factors tends to be higher for women in the unemployed or not in the labour force 
category, but again it is not as consistent across risk factors for men. The differences between employment 
status more often are greater for women than for men (Fig. 16 and Annex 1, Table A1.15). While variance 
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occurs between men and women by risk factor and country, prevalence of raised blood pressure (including 
both those on medication and those not on medication) consistently is higher for men and women who are 
unemployed or not in the labour force. Being unemployed or not in the labour force may present similar 
exposure to raised blood pressure for both men and women in the countries, while other risk factors, such 
as obesity, have a stronger association for women and employment status than for men.
 
Once again, variance occurs by risk factor and country across these two variables. While raised blood 
pressure shows little variance in the countries analysed by income level, more significant differences are 
shown in the countries analysed by employment status. Overall, the differences are often more pronounced 
by employment status than income level, especially among women. This may be due to sociodemographic 
variables and/or the country analysed. 
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GENDER AND OTHER DETERMINANTS: MIGRATION, MARITAL STATUS AND ETHNICITY
Other sociodemographic variables chosen by some countries for analysis provide further evidence of the 
importance of disaggregating data and comparing differences among subgroups of men and women. A 
health survey for migrants in Georgia, carried out in 2012 by the International Organization for Migration 
and the National Centre for Disease Control and Public Health of Georgia, used the STEPS questionnaire 
and other instruments and provides a comparison with a vulnerable subgroup. Knowledge and awareness 
of major NCDs and their risk factors was quite low among the migrant population, who often face even 
higher barriers in accessing services than the greater population (25). 
Illnesses migrants and ethnic minorities experience generally are the same as those found in the greater 
population, but prevalence rates can be higher, especially with CVDs. In the case of Georgia, an analysis of 
the prevalence of three or more NCD risk factors by age among subgroups reveals important differences. 
From the STEPS surveys of 2010 and 2016, the percentages of men and women with three or more risk 
factors generally decrease in each age group in the overall population, but among the migrant population, 
the percentages of both men and women with multiple risk factors are lower than for the greater 
population in the 18–29 age group and higher in all other age groups. The increase is especially drastic 
from the 18–29 to the 30–44 age groups for men and (especially) women, revealing that not only are the 
percentages higher among the migrant population, but also that the accumulation of risk factors by age 
group is different to that of the greater population (Fig. 17 and Annex 1, Table A1.16). 
 
Differences in prevalence of behavioural risk factors among migrant men and women in Georgia are 
similar to those in the greater population, but prevalence of biological risk factors more often is higher. 
Other differences are also observed, such as an opposite association between overweight and obesity 
a 60–64 (2010 migrant survey); 60–69 (STEPS 2016).
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and eduation level among migrant women than among women in the greater population. Important 
differences are hiding in the data between not only men and women, but also among subgroups of 
men and women, because gender and sociodemographic differences are associated with differences in 
exposure to risk factors.
Marital status was chosen as a sociodemographic variable to be included in the analysis by Belarus and 
Uzbekistan, highlighting another disaggregation for comparison. Prevalence of behavioural risk factors 
for men and women by marital status in these two countries reveals few significant differences, primarily 
among men, and no consistent trends across risk factors and countries. Prevalence among biological risk 
factors, however, more often is higher among men and women who currently are living with a partner 
(currently married or cohabitating) than those living without. The association is not always similar for men 
and women, however. While differences by marital status are similar for men and women in prevalence 
of overweight and obesity, for example, the differences in prevalence of raised blood pressure and raised 
cholesterol are greater for men than women (Fig. 18 and Annex 1, Table A1.17). 
An analysis by ethnicity was also used in two country profiles to examine additional differences due to the 
social influence of ethnicity on health behaviours and how gender roles may vary across ethnic groups. 
Ethnicity data were collected during the STEPS survey included in the country profiles of Kyrgyzstan and 
the Republic of Moldova. 
Some significant differences in behavioural risk factors among men and women by ethnicity are observed 
in Kyrgyzstan. Ethnic Russian men and women tend to have a higher prevalence of behavioural risk factors 
than other ethnic groups, and significant differences between men and women in each ethnic group 
are also prevalent. The overall trend of biological risk factors is that prevalence is higher for Kyrgyz and 
ethnic Uzbek men, but prevalence is higher for ethnic Russian women (Fig. 19 and Annex 1, Table A1.18). 
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While differences between men and women are observed among all three ethnic groups, they are more 
pronounced between ethnic Russian men and women.
 
Some significant differences are also observed in behavioural and biological risk factors by ethnicity in the 
Republic of Moldova, but they vary by risk factor and ethnic group. For example, ethnic Ukrainian men and 
women are lower than other ethnic groups in several behavioural risk factors, but prevalence for them 
tends to be higher across biological risk factors. Additionally, prevalence for Moldovan/Romanian men 
and women tends to be higher across biological risk factors compared to other ethnic groups. This again 
demonstrates the need for disaggregated data in each country as differences are found even among the 
same ethnic group (Russian men and women) across countries.
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Gender impacts the way men and women use services and the responses  
they receive
 
Gender norms, roles and relations impact the way men and women use services and the responses they 
receive from health providers (6,18). Health-seeking behaviour is affected by gender norms around what 
it means to be a man or woman, with traditional masculinities often acting as a barrier to men seeking 
health care, preventive behaviours and managing self-care, while women’s health is often delegated to 
sexual, reproductive and maternal health. This has implications for the services men and women access 
and how they are perceived when they access those services. Men’s limited health-seeking can affect the 
identification and management of biological risk factors. Gender biases can also impact the provision 
and quality of services received (26). For example, when women raise concerns that are unrelated to 
sexual, reproductive or maternal health, they may not be believed by health workers (27). Health workers’ 
lack of understanding of the gendered nature of service utilization compounds these issues. Current 
commitments towards universal health coverage require a holistic approach to men’s and women’s health, 
one that considers how gender norms, roles and relations affect access to and use of services, as well as 
the responses received.
In addition to the differences observed between and among men and women in NCD risk factors, significant 
differences are found between men and women in accessing services for NCDs. Though the percentages 
of men and women not measured for these risk factors vary considerably by country, the trend across 
countries is that more men than women have not had their blood pressure, blood glucose or cholesterol 
measured by a health professional (Fig. 20 and Annex 1, Table A1.19). 
Differences in access between men and women varies not only by country, but also by risk factor. A 
significantly higher percentage of men than women in Georgia and Kyrgyzstan have not had their blood 
pressure and blood glucose measured by a health-care professional, but the higher percentage of men 
* Statistically significant dierence.
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who did not have their cholesterol measured in these countries is not significant. Other countries, such as 
Belarus and Ukraine, followed the trend of higher percentages of men not having been measured, but the 
differences are not statistically significant. 
 
An analysis of accessing services by age groups reveals that the differences between men and women 
typically become significant in older age groups. As is to be expected, fewer men and women in the 
younger age groups have been measured for these risk factors than those in the older age groups. However, 
whereas significantly more women in the older age groups are accessing services (when they are more at 
risk), the same increase in access is not seen among men in the older age groups. This significant difference 
in access between men and women typically first appears in the 45–59 age group (Annex 1, Table A1.20). 
Gender inequality impacts access to, and use of, health resources
 
In the 2019 SDG Gender Index (an index that scores the state of gender equality in each country), the 
countries ranged in rank from 36 (Belarus) to 70 (Turkey) (28). Gender norms and roles remain strong 
and are considered traditional throughout this part of the Region, with women primarily being expected 
to take responsibility for the household and family while men primarily are expected to be the main 
income earners (29–32). Though it varies among countries, public polling shows that these norms are often 
supported by a majority of both men and women. 
Worldwide, women spend between two and 10 times more time on unpaid care, in addition to their paid 
activities. Women’s increased unpaid care burden impacts their overall health and well-being by affecting 
their labour-force participation, quality of employment (more part-time and vulnerable employment), 
wages, free time and mental health (32). Men’s role as the main income earners can also affect men’s 
mental health and ability to access and use health services. 
Measures have been taken to address gender inequality in each of these countries. In recent years, 
legislation and national plans have been adopted specifically to address gender issues, including 
discrimination based on gender, equality in public services, violence against women, addressing women’s 
unpaid care burden (33) and establishing national councils on gender equality (19,20,29,34–36). Despite 
these measures, popular narratives of gender inequality persist.
Examining differences in accessing services not only between, but also among men and among women is 
necessary to identify inequalities and understand needs and barriers. An analysis of additional differences 
by sociodemographic groupings reveals more differences between, and variance among, men and women. 
While differences are observed in the analysis of risk factors, there is often variance by sociodemographic 
group. Trends observed in the associations between sociodemographic groups and accessing services, 
however, are more pronounced across countries. In other words, groups within geographic location, 
education level and employment/income have consistent associations for both men and women across 
access measurements. More women and men in rural areas, in the low education level, and who are in 
the low income and unemployed or not in the labour force categories have not been measured for these 
risk factors. 
30
GENDER AND NONCOMMUNICABLE DISEASES IN EUROPE
ACCESS BY GEOGRAPHIC LOCATION 
The percentages of men and women not measured for these risk factors are more often higher in rural 
areas than in urban. This trend is consistent across nearly all countries and risk factors (Fig. 21 and Annex 1, 
Table A1.21). Additionally, there are important differences among men and among women by geographic 
location.
 
The percentages of rural women not measured often are not significantly different than those of men in 
urban areas who have not been measured. As prevalence of biological risk factors for men and (especially) 
women often is higher in rural areas than in urban, identifying not only which groups of men and women 
experience higher prevalence, but also which are not accessing services, is important in efforts to prevent 
and manage NCDs. For example, significantly more men than women overall in Kyrgyzstan have not had 
their blood glucose measured. This analysis by place of residence highlights differences within groups of 
men and women in being measured, with the percentage of rural women not measured being as high as 
the percentage for urban men. This illustrates the need to identify which groups are in need of targeted 
interventions to improve access, in this case not only men, but also rural women. Acting on aggregated data 
alone may lead to missed opportunities to target groups among men and among women experiencing 
barriers to accessing services.  
ACCESS BY EDUCATION LEVEL
The percentages of those not measured for blood pressure, blood glucose and cholesterol consistently 
are higher for low-education men and women than those with high education. The differences between 
low and high education in not being measured, however, are often greater for men than women. The 
percentages of high-education men who have not been measured are often not significantly higher than 
for women in the low and even high education level, showing that low-education men are often driving 
the overall higher percentage of men who have not been measured (Fig. 22 and Annex 1, Table A1.22).
 
As mentioned in the analysis of risk factors, prevalence of raised blood pressure is observed to be higher 
for men and women with low education, but it varies by country. As more low-education women and men 
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have not been measured for raised blood pressure, this presents further support for a gender-analysis 
approach to identify which subgroups within the population are both at greater risk and are underserved. 
In this case, the percentage of low-education men who have not been measured appears to be driving the 
difference between men and women overall. An examination of the barriers faced by low-education men 
in accessing services may be warranted in many of these countries.
ACCESS BY EMPLOYMENT STATUS/INCOME LEVEL
Though not all differences are statistically significant, a general trend that more men and women who are 
in the low-income category have not been measured for these risk factors is observed (Fig. 23 and Annex 1, 
Table A1.23). The differences are more pronounced with blood glucose and cholesterol than with blood 
pressure, and in most cases the difference between high and low income is greater for women than for 
men. Both men and women may be facing barriers to accessing services that are associated with income 
level, but the association appears to be different for men and women.  
 
Similarly, the trend with employment status and being measured for risk factors is that more men and 
women who are in the unemployed or not in the labour force category have not been measured for 
these risk factors, but there are exceptions (Fig. 24 and Annex 1, Table A1.24). Most differences are not 
significant, but in the Republic of Moldova, the percentage of women who are unemployed or not in the 
labour force who have not had their blood glucose or cholesterol measured is significantly higher than for 
employed women. An exception to the trend is Belarus, where the percentage of employed women whose 
cholesterol has not been measured is significantly higher than for women who are unemployed or not 
in the labour force. These significant differences, in addition to the exceptions to trends, provide further 
evidence for examining groups within a population.
 
Though more men than women generally have not been measured for risk factors, it is often observed that 
by income or employment status, fewer women than men in some subgroups have been measured. Efforts 
to analyse access or identify barriers for men and women therefore should not treat men and women as 
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homogenous groups. This is especially important because the prevalence of biological risk factors is higher 
for women in the low-income and unemployed or not in the labour force groups than it is for employed 
and high-income women, and the differences by employment status/income levels are greater for women 
than for men.
Fewer men overall have been measured for risk factors, but the differences among men and among women 
are equally important. Men and women in low-education, rural and low-income/unemployed or not in the 
labour force groups have been measured less. Additionally, the percentages of women not measured 
in the low-education, rural and low-income/unemployed or not in the labour force groups often are no 
different than the percentages of high-education, urban and employed/high-income men not measured. 
The differences hiding even in sex-disaggregated data need to be identified if progress is to be made in 
preventing and managing NCDs in the population.  
ACCESS AND MIGRATION, MARITAL STATUS AND ETHNICITY  
Other observable differences in accessing services emerge when the analysis of data includes variables 
examining subgroups such as migrants and ethnic minorities as well as differences between men and 
women according to marital status. Migrants often face various barriers to accessing services, even beyond 
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those associated with migrant status. In the case of Georgia, data from the migrant health survey can be 
used alongside the STEPS data to show how a subgroup compares to the larger population. Access for 
both men and women in the greater population improved from 2010 to 2016. The snapshot of access 
for migrant men and women in 2012 shows higher percentages not being measured than in the overall 
population in 2016, but these are lower than the percentages of the 2010 STEPS survey (Fig. 25 and Annex 1, 
Table A1.25). An analysis of groups within the migrant population by age, education level and employment 
status reveals that percentages of those not measured for risk factors generally are higher among migrant 
men and women. 
 
Differences in access by marital status can vary for men and women and by country. While some differences 
are observed for men in Belarus, virtually no differences are seen for women. In Uzbekistan, however, 
greater differences are observed for both men and women, and higher percentages of both men and 
women not being measured are found among those currently living with a partner (Fig. 26 and Annex 1, 
Table A1.26). Marital status may be associated with accessing services differently for men and women, and 
it varies by country. 
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A comparison of men and women belonging to majority and minority ethnic groups in Kyrgyzstan and 
the Republic of Moldova does not reveal significant differences or trends in accessing services. Members 
of different minority ethnic groups in these countries may not experience the same barriers to access. 
An analysis of a majority ethnic group compared with several minority groups, as was performed with 
Kyrgyzstan, may reveal important differences and similarities between ethnic groups. In this case, more 
men and women belonging to the majority ethnic group (Kyrgyz) and a minority ethnic group (Uzbek) were 
not measured for risk factors than another minority ethnic group (Russian) (37). 
 
Gender stereotypes may be ignored, perpetuated or challenged by health 
promotion efforts to prevent NCDs
 
One way in which gender stereotypes play a role in health promotion is through interactions with health-
care professionals. The STEPS survey provides self-reported accounts of participants’ interactions with 
health-care professionals regarding lifestyle advice on NCD-related risk factors. Findings from a recent 
WHO report can be applied to behavioural risk on how notions of masculinities impact men’s access to 
services and the responses they receive (38).
Men and women access services differently, and the responses they receive when they access services can 
also differ. The STEPS survey gathered information on whether men and women had been given lifestyle 
advice when they had visited a health-care professional. The topics under lifestyle advice can be compared 
with the prevalence of related risk factors (Table 2) to examine more differences between sexes. 
Across countries, a significantly higher percentage of men than women have been given advice on avoiding 
tobacco use. On the remaining lifestyle advice topics, a higher percentage of women across countries 
report having been given advice, or there is no significant difference (Fig. 27 and Annex 1, Table A1.27).
 
The percentages of those receiving lifestyle advice in some cases are lower and in other cases higher than 
the prevalence of the related risk factors. The difference in lifestyle advice given to men and women, and 
the corresponding prevalence of the related risk factors, warrants further analysis.
Table 2. Lifestyle advice topics and prevalence of related risk factors  
Lifestyle advice topic Related risk factor
Quit using tobacco or don’t start Current tobacco use
Reduce salt in your diet Unhealthy diet (added salt)
Eat at least five servings of fruit and/or vegetables each day Unhealthy diet (< 5 fruit/veg)
Start or do more physical activity Insufficient physical activity
Maintain a healthy body weight or lose weight Overweight (BMI ≥ 25)
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* Statistically significant dierence.
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This report and the accompanying country profiles are the first gender analyses of NCD risk-factor data 
for adults in participating counties and make an important contribution to, and serve as an evidence 
base for, enabling achievement of the WHO European Programme of Work (39), the SDGs, women’s and 
men’s health strategies (1,2), the European Action Plan for the Prevention and Control of Noncommunicable 
Diseases (3) and other international commitments on NCDs, and promoting improved use of disaggregated 
data for better health outcomes, gender equality and human rights. The report and country profiles are 
also important tools in accelerating action towards reducing the NCD burden and ensuring universal 
health coverage by unpacking inequalities by sociodemographic determinants in NCD risk factors and 
health system response, and contribute to raising awareness and building capacity among country-based 
researchers and policy-makers on the rationale for applying a gender analysis to health data. 
Globally, more than 100 countries have collected data through the STEPS surveys, but this series is the 
first time a more in-depth analysis from a gender perspective has been conducted. The following findings 
of the gender analysis across the eight countries therefore can be used to address specific needs and 
policy opportunities for similar countries in the Region. The findings represent observed trends, and data 
presented in the report are disaggregated to show variance by country.
Men and women not only engage differently in behavioural risk factors, but also have different risk 
factor trajectories for both behavioural and biological risk factors over the life-course. Significantly higher 
percentages of men than women in most age groups engage in behavioural risk factors for NCDs. Higher 
prevalence in biological risk factors is observed among women in the older age groups than in men, while 
generally there is lower prevalence in younger age groups of women than in men. The percentages of men 
and women with multiple risk factors increase with each age group, but the increase for women often 
is more drastic, causing the differences in percentages between men and women to lessen with each 
ascending age group. While the percentages of men with multiple risk factors typically double from the 
youngest to the oldest age groups, the increase in the percentages of women is from three to 11 times 
greater between comparable age groups. The importance of disaggregation by sex and age becomes 
apparent when significant differences are found to be hiding in the aggregated percentages of risk factors 
for men and women. Higher levels of male premature mortality could also contribute to lower prevalence 
of multiple risk factors among male survivors at older ages, but additional causes of difference in risk 
factors between men and women should also be explored.
The analysis shows that prevalence of both behavioural and biological risk factors can vary in subgroups 
of men and women and by country, and these subgroups are not equal in their relation to the risk factors. 
Identifying groups most at risk necessarily requires disaggregation of data and a gender analysis that 
links sex with age and other relevant sociodemographic variables. The additional analysis by geographic 
location, education, income and employment status further showcases the differences across behavioural 
and biological risk factors not only between, but also among, men and women. 
Differences were observed for men in the analysis of risk factors by geographic location, but they vary, with 
no clear trend across countries. Prevalence of behavioural risk factors tends to be higher for urban women, 
however, and prevalence of biological risk factors generally is higher for women in rural areas. The analysis 
by education level reveals that prevalence of behavioural risk factors for men and women varies across 
countries, with low-education categories higher in some risk factors and high-education categories higher 
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in others. The trend for biological risk factors and education levels is more consistent, with prevalence 
generally being higher for high-education men and low-education women than other levels; the difference 
is greater for women, but again varies by country. More high-income and employed men and women 
engage in behavioural risk factors, while those with low incomes or who are unemployed or not in the 
labour force are linked with higher prevalence of biological risk factors for men and (especially) women. 
These differences further emphasize the need for a gender analysis to identify subgroups at risk and inform 
targeted interventions.
Other social determinants, such as migration, marital status and ethnicity, also provide insights into 
subgroups among men and among women regarding risk factors. In Georgia, migrant men and women 
have higher prevalence of multiple NCD risk factors than the overall population. An analysis by marital 
status in Belarus and Uzbekistan reveals higher prevalence of biological factors for men and women 
currently living with a partner than those living without, but the association varies between men and 
women. Prevalence of current tobacco use is higher among ethnic minority men and women in Kyrgyzstan 
and the Republic of Moldova, prevalence of alcohol consumption is higher among ethnic majority men and 
women, and the other behavioural risk factors vary by ethnicity. These additional examples of determinants 
demonstrate the importance of examining risk factors among men and among women by country, as they 
relate to gender norms and practices among different groups.
Important differences are also observed in accessing services across countries. A higher percentage of 
men have not been measured for biological risk factors, while a higher percentage of women compared 
to men are being given lifestyle advice on most behavioural risk factors. Despite accessing services more, 
the prevalence of biological risk factors as measured during the STEPS survey remains higher for women 
than men, or are not significantly different. This may in part be due to differences in accessing services  for 
men and women as observed through disaggregation by age, geographic location, education, income and 
employment status. 
While fewer men and women in rural areas than in urban have been measured for risk factors, the 
percentages of women measured in rural areas are not significantly different than those of men measured 
in rural and urban areas. Both men and women in the low education level have been measured for 
risk factors less than those in the high education level. More men and women in the low-income and 
unemployed or not in the labour force groups have not been measured for risk factors than employed and 
high-income men and women. 
More migrant men and women in Georgia have not been measured for risk factors than those in the 
greater population, warranting further examination into barriers that may be affecting migrant groups. 
Access and marital status vary in association between men and women in Belarus and Uzbekistan, with 
greater differences observed in Uzbekistan. Differences in being measured by ethnic group in Kyrgyzstan 
reveal the importance of examining minority groups separately compared to the majority group; differences 
are observed among minority groups, demonstrating that majority–minority status may present different 
experiences or barriers for different groups.
Improving access to services for women and men may therefore require that additional attention is paid 
to specific groups, including the following: men and (especially) women in rural areas, men and women in 
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the low education level, low-income and unemployed or not in the labour force men and women, migrant 
men and women, and some ethnic minority groups.
The significantly higher percentages of lifestyle advice given to women could be influenced by numerous 
factors, including women’s higher frequency of interaction with health-care services, the greater proportion 
of women (especially in the older age groups) with biological risk factors, and cultural and gender norms. 
There is a need to identify gender-specific norms and barriers to access and lifestyle change. Barriers are 
both gender- and disease-specific, with men and women experiencing them differently depending on the 
risk factor and sociodemographic characteristics (40). These barriers can be identified and explored through 
studies that engage specific sociodemographic groups through quantitative and qualitative approaches. 
Such approaches could also explore possible influences such as the presence of implicit bias in provider 
counselling, the gender of the health-care professional and social norms regarding social interactions 
between men and women. Gender-sensitive and culturally appropriate responses would then facilitate 
behavioural change and access to, and use of, services. An analysis of the impact of gender inequalities 
requires further quantitative and qualitative information that cannot be retrieved from the STEPS data.
Findings presented in this report highlight the importance of an in-depth gender analysis of existing 
sex-disaggregated data together with other variables in identifying NCD risk-factor differences not only 
between men and women, but also among men and women. The analysis will further reveal specific needs 
and opportunities in prevention and management of NCDs among different population groups that can 
then be addressed through tailored interventions. 
Accompanying this synthesis report are eight country profiles, each with key findings and variables 
specific to country data. The gender analysis is being extended to other available surveys (including the 
global adult and youth tobacco surveys, the Health Behaviour in School-aged Children study and the 
WHO European Childhood Obesity Surveillance Initiative) to obtain more compressive insights. Studies 
that specifically examine gender and social norms in these contexts can be used to complement these 
surveys by identifying driving and constraining factors for behaviours causing differences between and 
among men and women. In addressing the areas identified in this report, cost-effective interventions 
like best-buy and other interventions recommended by WHO (13) should be prioritized and tailored to the 
country-specific context to ensure uptake and efficiency. This would greatly contribute to the achievement 
of universal health coverage and the health-related SDGs.
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Table A1.2. Total mortality per 1000
Country Mortality per 1000 – all causes Men Women
Armenia
Age 45–59 19.73 7.15
Age 60–69 53.51 22.95
Belarus
Age 45–59 12.99 4.02
Age 60–69 34.55 11.32
Georgia
Age 45–59 26.05 8.70
Age 60–69 60.32 25.34
Kyrgyzstan
Age 45–59 25.36 10.40
Age 60–69 62.62 30.39
Republic of Moldova
Age 45–59 29.12 11.00
Age 60–69 73.54 34.95
Turkey
Age 45–59 9.97 4.79
Age 60–69 33.99 16.79
Ukraine
Age 45–59 42.02 14.40
Age 60–69 102.88 39.97
Uzbekistan
Age 45–59 16.74 9.14
Age 60–69 49.44 31.23
Source: WHO (2).
Table A1.1. Burden of disease for men and women, expressed through DALYsa per 100 000 population, 2017
Country
Neonatal 
disorders
Diarrhoea, lower 
respiratory and 
other common 
infectious diseases
Mental and 
substance-
use disorders Diabetes
Other 
NCDs CVDs
All 
causes
Armenia
Men 823.6 844.0 1 920.6 1 640.7 1 577.7 9 157.0 33 509.2
Women 622.6 582.6 1 745.1 1 791.5 1 658.7 6 486.7 26 938.5
Belarus
Men 802.1 726.5 4 154.1 651.0 1 110.8 15 378.2 45 354.5
Women 651.5 294.8 2 986.0 684.7 1 433.4 11 213.7 33 471.1
Georgia
Men 1 267.9 947.3 1 995.4 1 919.4 1 162.2 15 614.4 44 881.7
Women 914.2 581.8 1 623.5 1 693.2 1 408.9 11 369.1 33 362.4
Kyrgyzstan
Men 3 353.6 1 580.0 2 305.1 530.6 1 369.5 6 404.7 29 934.6
Women 2 461.4 1 193.8 1 657.3 514.8 1 693.0 4 543.6 23 377.0
Republic of 
Moldova
Men 1 163.2 1 712.3 3 047.6 858.9 1 437.5 12 826.3 44 961.3
Women 954.2 648.0 2 409.8 938.9 1 663.3 9 845.6 33 368.1
Turkey
Men 1 164.6 650.4 2 615.2 1 004.9 1 448.4 4 468.1 25 880.1
Women 1 034.7 483.3 2 315.9 944.8 1 594.1 2 878.1 21 112.3
Ukraine
Men 814.2 1 418.1 3 988.0 834.4 1 285.9 20 639.0 57 985.2
Women 691.7 621.3 2 787.9 820.3 1 614.0 13 754.7 38 417.3
Uzbekistan
Men 2 164.5 2 859.0 1 913.5 1 229.7 1 190.5 9 155.3 32 568.8
Women 1 394.4 2 275.3 1 575.6 1 120.7 1 494.7 6 302.2 25 973.5
WHO
European 
Region
Men 800.8 985.6 2 786.6 978.0 1 128.2 8 387.4 34 978.1
Women 639.5 637.3 2 434.0 887.2 1 363.3 6 208.5 28 690.9
a DALYs: disability-adjusted life years. Source: Institute for Health Metrics and Evaluation (1). 
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Table A1.3. Prevalence of behavioural risk factors
Country Risk factors
Men
% (CI 95%)
Women 
% (CI 95%)
Armenia
Current tobacco use 51.5 (47.4–55.6) 1.8 (1.1–2.5)
Alcohol consumption Currently drink 46.1 (40.2–52.0) 21.5 (18.6–24.3) 
Heavy episodic drinking 11.1 (8.1–14.0) 0.1 (0.0–0.3)
Unhealthy diet < 5 fruit or vegetables per day 78.4 (74.3–82.4) 73.5 (70.4–76.6) 
Always or often add salt 40.3 (36.1–44.4) 30.1 (27.1–33.1)
Always or often eat processed foods 34.3 (30.0–38.7) 27.8 (24.8–30.7)
Insufficient physical activity 22.0 (18.0–26.1) 20.4 (17.3–23.5) 
Belarus
Current tobacco use 48.4 (45.5–51.3) 12.6 (11.1–14.0)
Alcohol consumption Currently drink 64.9 (61.6–68.3) 41.8 (38.6–44.9)
Heavy episodic drinking 35.0 (31.8–38.1) 6.9 (5.6–8.2)
Unhealthy diet < 5 fruit or vegetables per day 77.9 (74.3–81.5) 68.4 (64.7–72.0)
Always or often add salt 35.8 (31.9–39.7) 28.0 (24.5–31.4)
Always or often eat processed foods 43.6 (40.4–46.8) 28.5 (25.9–31.1)
Insufficient physical activity 12.8 (10.7–14.9) 13.5 (11.5–15.5)
Georgia
Current tobacco use 57.0 (53.6–60.3) 7.0 (5.8–8.2)
Alcohol consumption Currently drink 58.9 (55.2–62.5) 20.7 (18.6–22.9)
Heavy episodic drinking 35.3 (31.2–39.4) 2.6 (1.7–3.5)
Unhealthy diet < 5 fruit or vegetables per day 63.8 (59.6–67.9) 62.4 (59.5–65.3)
Always or often add salt 33.4 (29.4–37.3) 20.6 (18.6–22.7)
Always or often eat processed foods 18.9 (15.3–22.5) 10.1 (8.7–11.5)
Insufficient physical activity 16.2 (13.6–18.9) 18.4 (16.3–20.4)
Kyrgyzstan
Current tobacco use 48.2 (43.6–52.8) 2.7 (1.7–3.7)
Alcohol consumption Currently drink 44.8 (37.1–52.4) 17.7 (14.3–21.2)
Heavy episodic drinking 22.8 (17.9–27.7) 2.7 (1.7–3.8)
Unhealthy diet < 5 fruit or vegetables per day 76.7 (71.3–82.2) 71.1 (65.6–76.7)
Always or often add salt 20.4 (14.7–26.1) 15.6 (11.9–19.4)
Always or often eat processed foods 28.5 (23.1–33.8) 25.3 (21.7–28.9)
Insufficient physical activity 8.9 (6.4–11.3) 14.1 (11.7–16.5)
Republic of 
Moldova
Current tobacco use 43.6 (40.6–46.7) 5.6 (4.5–6.7)
Alcohol consumption Currently drink 69.8 (66.3–73.2) 53.5 (50.5–56.4)
Heavy episodic drinking 29.0 (25.4–32.6) 9.2 (7.6–10.9)
Unhealthy diet < 5 fruit or vegetables per day 65.8 (62.1–69.5) 67.5 (64.5–70.6)
Always or often add salt 28.0 (24.7–31.3) 20.3 (18.1–22.5)
Always or often eat processed foods 36.5 (33.2–39.8) 28.1 (25.4–30.7)
Insufficient physical activity 10.7 (8.5–12.9) 9.4 (7.7–11.1)
Turkey
Current tobacco use 43.4 (40.8–46.0) 19.7 (17.6–21.8)
Alcohol consumption Currently drink 13.1 (11.2–15.0) 3.0 (2.1–4.0)
Heavy episodic drinking 8.7 (7.0–10.3) 1.8 (1.0–2.6)
Unhealthy diet < 5 fruit or vegetables per day 87.8 (85.8–89.8) 87.9 (86.3–89.5)
Always or often add salt 29.3 (26.7–31.9) 26.8 (24.6–29.0)
Always or often eat processed foods 27.8 (25.3–30.3) 23.3 (21.0–25.6)
Insufficient physical activity 33.1 (30.5–35.6) 53.9 (51.6–56.3)
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Country Risk factors
Men
% (CI 95%)
Women 
% (CI 95%)
Ukraine
Current tobacco use 50.3 (43.6–57.1) 16.7 (14.3–19.1)
Alcohol consumption Currently drink 66.1 (60.9–71.4) 44.6 (41.1–48.1)
Heavy episodic drinking 29.5 (20.7–38.4) 9.4 (7.2–11.6)
Unhealthy diet < 5 fruit or vegetables per day 73.2 (67.9–78.6) 59.4 (55.3–63.6)
Always or often add salt 53.0 (46.3–59.7) 36.5 (32.5–40.4)
Always or often eat processed foods 32.5 (27.0–38.0) 21.1 (18.2–24.1)
Insufficient physical activity 9.1 (6.6–11.7) 10.8 (8.3–13.3)
Uzbekistan
Current tobacco use 18.8 (15.3–22.2) 0.5 (0.2–0.9)
Alcohol consumption Currently drink 8.7 (6.1–11.3) 0.8 (0.3–1.4)
Heavy episodic drinking 2.7 (1.6–3.8) 0.2 (0.0–0.5)
Unhealthy diet < 5 fruit or vegetables per day 14.7 (11.4–18.1) 17.2 (14.3–20.1)
Always or often add salt 34.4 (29.2–39.6) 38.7 (34.6–42.7)
Always or often eat processed foods 34.0 (28.1–40.0) 38.3 (34.4–42.1)
Insufficient physical activity 20.5 (16.7–24.4) 31.2 (27.2–35.3)
 CI: confidence interval.
Table A1.4. Prevalence of biological risk factors
Country Risk factors
Men
% (CI 95%)
Women 
% (CI 95%)
Armenia
Overweight (BMI ≥ 25 kg/m2) 45.4 (40.6–50.2) 50.1 (46.7–53.5)
Obesity (BMI ≥ 30 kg/m2) 14.0 (10.9–17.0) 25.0 (22.4–27.7)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 39.3 (34.3–44.2) 36.3 (32.9–39.7) 
Raised BP (NOT on medication) 33.9 (28.8–38.9) 27.2 (24.0–30.4)
Raised blood glucose (or on medication) 6.5 (3.9–9.2) 4.6 (3.4–5.8)
Raised cholesterol (or on medication) 22.6 (17.9–27.3) 24.8 (22.0–27.6) 
Belarus
Overweight (BMI ≥ 25 kg/m2) 61.5 (58.7–64.2) 60.0 (57.3–62.4)
Obesity (BMI ≥ 30 kg/m2) 20.2 (17.9–22.4) 30.2 (27.9–32.5)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 45.6 (42.7–48.6) 44.2 (41.9–46.5)
Raised BP (NOT on medication) 35.3 (32.1–38.4) 25.2 (22.9–27.6)
Raised blood glucose (or on medication) 3.2 (2.3–4.1) 3.9 (2.9–5.0)
Raised cholesterol (or on medication) 33.4 (30.6–36.2) 42.6 (40.0–45.2)
Georgia
Overweight (BMI ≥ 25 kg/m2) 65.5 (61.4–69.7) 63.8 (61.4–66.3)
Obesity (BMI ≥ 30 kg/m2) 30.2 (26.9–33.6) 36.0 (33.7–38.2)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 38.6 (35.1–42.2) 36.9 (34.7–39.1)
Raised BP (NOT on medication) 28.7 (25.2–32.3) 21.6 (19.4–23.8)
Raised blood glucose (or on medication) 4.7 (3.5–6.0) 4.3 (3.4–5.2)
Raised cholesterol (or on medication) 21.9 (18.6–25.2) 33.0 (30.4–35.6)
Kyrgyzstan
Overweight (BMI ≥ 25 kg/m2) 49.4 (42.4–56.5) 63.5 (60.2–66.8)
Obesity (BMI ≥ 30 kg/m2) 17.6 (14.4–20.8) 29.0 (26.2–31.8)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 42.7 (38.0–47.4) 43.0 (39.7–46.4)
Raised BP (NOT on medication) 38.9 (34.3–43.6) 35.4 (32.1–38.7)
Raised blood glucose (or on medication) 5.1 (3.7–6.6) 5.1 (3.6–6.5)
Raised cholesterol (or on medication) 17.5 (14.6–20.4) 29.9 (25.4–34.3)
Republic of 
Moldova
Overweight (BMI ≥ 25 kg/m2) 56.0 (52.7–59.4) 55.9 (53.1–58.7)
Obesity (BMI ≥ 30 kg/m2) 17.8 (15.6–20.0) 28.5 (26.3–30.7)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 40.3 (37.0–43.7) 39.3 (36.6–42.1)
Raised BP (NOT on medication) 35.9 (32.4–39.3) 30.1 (27.3–32.9)
Raised blood glucose (or on medication) 11.5 (9.5–13.5) 13.0 (11.4–14.6)
Raised cholesterol (or on medication) 26.7 (23.5–29.9) 32.0 (29.3–34.8)
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Country Risk factors
Men
% (CI 95%)
Women 
% (CI 95%)
Turkey
Overweight (BMI ≥ 25 kg/m2) 62.8 (60.2–65.4) 66.0 (63.7–68.4)
Obesity (BMI ≥ 30 kg/m2) 21.6 (19.5–23.8) 35.9 (33.8–38.0)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 29.3 (27.2–31.5) 44.2 (41.9–46.5)
Raised BP (NOT on medication) 17.3 (15.4–19.3) 25.2 (22.9–27.6)
Raised blood glucose (or on medication) 10.6 (8.3–13.0) 11.5 (9.1–13.9)
Raised cholesterol (or on medication) 20.9 (17.6–24.1) 28.5 (25.0–31.9)
Ukraine
Overweight (BMI ≥ 25 kg/m2) 58.0 (50.4–65.5) 60.2 (57.0–63.4)
Obesity (BMI ≥ 30 kg/m2) 20.1 (15.5–24.8) 29.8 (26.5–33.1)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 34.5 (28.7–40.3) 35.0 (31.7–38.4)
Raised BP (NOT on medication) 30.8 (25.2–36.4) 28.7 (25.4–32.1)
Raised blood glucose (or on medication) 6.7 (4.7–8.7) 7.4 (5.8–9.0)
Raised cholesterol (or on medication) 40.5 (34.9–46.0) 40.5 (36.4–44.7)
Uzbekistan
Overweight (BMI ≥ 25 kg/m2) 55.6 (50.8–60.4) 57.3 (53.8–60.8)
Obesity (BMI ≥ 30 kg/m2) 21.5 (17.8–25.3) 25.5 (22.9–28.2)
Raised blood pressure 
(BP)
Raised BP (or on medication for raised BP) 38.5 (33.4–43.6) 37.4 (33.3–41.5)
Raised BP (NOT on medication) 29.6 (25.4–33.8) 24.1 (21.2–27.1)
Raised blood glucose (or on medication) 8.6 (6.8–10.4) 8.2 (6.7–9.6)
Raised cholesterol (or on medication) 10.3 (7.9–12.8) 13.9 (12.0–15.9)
 CI: confidence interval.
Table A1.5. Prevalence of three or more risk factors
Country Age group
Men
% (CI 95%)
Women
% (CI 95%)
Armenia
18–29 26.6 (19.3–34.0) 5.0 (2.1–7.9)
30–44 42.7 (32.9–52.5) 23.6 (18.9–28.4)
45–59 62.1 (53.1–71.1) 46.2 (40.7–51.8)
60–69 55.7 (45.1–66.3) 66.3 (59.4–73.2)
Belarus
18–29 25.1 (20.2–30.0) 9.4 (5.5–13.2)
30–44 46.4 (41.6–51.3) 22.8 (19.5–26.2)
45–59 57.5 (53.4–61.6) 45.2 (41.3–49.1)
60–69 71.8 (66.6–77.0) 59.8 (54.9–64.8)
Georgia
18–29 29.2 (21.7–36.8) 7.9 (4.5–11.3)
30–44 44.9 (37.8–52.0) 15.9 (12.7–19.1)
45–59 57.2 (50.8–63.5) 38.9 (35.2–42.7)
60–69 50.8 (43.5–58.0) 51.2 (46.4–56.1)
Kyrgyzstan
18–29 23.0 (16.1–30.0) 12.5 (9.0–16.1)
30–44 41.9 (33.5–50.2) 26.7 (21.3–32.2)
45–59 57.6 (49.6–65.5) 43.2 (36.9–49.5)
60–69 54.7 (44.9–64.5) 53.6 (46.0–61.2)
Republic of Moldova
18–29 29.2 (21.7–36.8) 7.9 (4.5–11.3)
30–44 44.9 (37.8–52.0) 15.9 (12.7–19.1)
45–59 57.2 (50.8–63.5) 38.9 (35.2–42.7)
60–69 50.8 (43.5–58.0) 51.2 (46.4–56.1)
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Country Age group
Men
% (CI 95%)
Women
% (CI 95%)
Ukraine
18–29 15.4 (10.2–20.7) 7.4 (3.5–11.3)
30–44 35.4 (22.9–47.9) 17.8 (13.1–22.5)
45–59 57.3 (48.1–66.6) 33.4 (28.1–38.8)
60–69 56.0 (48.5–63.6) 46.8 (40.6–52.9)
Uzbekistan
18–29 6.0 (2.2–9.8) 6.6 (3.1–10.2)
30–44 15.9 (11.6–20.2) 15.4 (1.7–12.0)
45–59 28.2 (23.7–32.8) 26.9 (22.7–31.0)
60–69 34.4 (27.5–41.3) 36.1 (22.7–31.0)
 CI: confidence interval.
Table A1.6. Prevalence of biological risk factors by age group
Country Risk factor
Aged 18–29
% (CI 95%)
Aged 30–44 
% (CI 95%)
Aged 45–59 
% (CI 95%)
Aged 60–69 
% (CI 95%)
Armenia
Overweight  
(BMI ≥ 25)
Men 30.7 (21.9–39.5) 45.0 (36.0–53.9) 60.0 (51.9–68.2) 60.2 (50.3–70.0)
Women 19.0 (13.3–24.8) 48.2 (42.7–53.6) 76.1 (71.5–80.6) 84.8 (79.7–89.9)
Obesity  
(BMI ≥ 30)
Men 3.8 (0.8–6.7) 14.1 (7.6–20.6) 24.9 (18.3–31.6) 20.7 (12.5–28.9)
Women 5.1 (2.2–7.9) 20.8 (16.3–25.4) 42.7 (37.2–48.3) 52.7 (46.1–59.3)
Raised blood pressure 
(or on medication)
Men 16.7 (9.9–23.5) 35.4 (27.4–43.4) 62.6 (53.3–71.9) 67.4 (58.5–76.2)
Women 9.6 (5.8–13.4) 28.3 (23.5–33.2) 61.2 (55.9–66.6) 78.3 (72.5–84.2)
Raised blood pressure 
(NOT on medication)
Men 15.1 (8.3–21.8) 31.5 (23.5–39.5) 56.8 (46.6–67.0) 57.5 (46.3–68.8)
Women 7.4 (3.7–11.0) 25.4 (20.5–30.3) 49.2 (43.1–55.3) 64.2 (55.6–72.8)
Raised blood glucose  
(or on medication)
Men 3.8 (0.5–7.1) 7.1 (0.5–13.7) 10.1 (5.0–15.1) 10.5 (4.3–16.7)
Women 1.1 (0.0–2.6) 3.2 (1.0–5.4) 6.7 (4.1–9.4) 14.3 (9.3–19.3)
Raised cholesterol 
(or on medication)
Men 11.5 (5.5–17.5) 25.1 (17.1–33.1) 36.2 (27.4–44.9) 38.9 (27.6–50.2)
Women 5.5 (2.7–8.4) 19.2 (14.1–24.2) 48.5 (42.7–54.3) 43.7 (36.0–51.4)
Belarus
Overweight  
(BMI ≥ 25)
Men 40.0 (33.7–46.2) 62.6 (57.7–67.4) 70.7 (66.9–74.6) 77.7 (72.9–82.5)
Women 23.6 (18.3–29.0) 49.3 (45.2–53.5) 80.1 (77.3–82.9) 83.8 (80.4–87.1)
Obesity  
(BMI ≥ 30)
Men 7.0 (4.0–9.9) 18.3 (14.8–21.8) 28.8 (24.8–32.7) 29.5 (24.0–35.1)
Women 6.7 (3.4–10.0) 21.1 (17.7–24.5) 43.0 (39.4–46.7) 50.1 (45.4–54.9)
Raised blood pressure 
(or on medication)
Men 17.0 (12.4–21.5) 35.1 (30.2–40.0) 64.4 (60.0–68.8) 81.8 (77.0–86.6)
Women 10.3 (7.1–13.4) 24.4 (20.8–28.0) 63.4 (60.1–66.7) 84.8 (81.6–88.1)
Raised blood pressure 
(NOT on medication)
Men 13.9 (9.5–18.4) 30.5 (25.7–35.3) 53.6 (48.5–58.8) 66.8 (58.9–74.7)
Women 8.0 (5.0–11.0) 17.1 (13.8–20.3) 43.3 (38.9–47.8) 58.5 (51.1–65.8)
Raised blood glucose  
(or on medication)
Men 0.5 (0.0–1.2) 1.1 (0.3–1.9) 5.7 (3.3–8.1) 7.4 (4.4–10.4)
Women 0.7 (0.0–1.4) 2.1 (0.8–3.3) 4.3 (2.8–5.7) 10.6 (7.2–14.1)
Raised cholesterol 
(or on medication)
Men 7.4 (4.1–10.8) 32.9 (28.2–37.6) 44.9 (40.5–49.3) 48.5 (41.9–55.1)
Women 15.2 (10.7–19.8) 30.7 (27.0–34.5) 57.0 (53.3–60.8) 66.5 (62.0–71.1)
Georgia
Overweight  
(BMI ≥ 25)
Men 45.9 (37.8–54.0) 66.3 (59.3–73.4) 78.3 (72.7–83.8) 73.0 (65.4–80.5)
Women 26.8 (21.5–32.1) 60.5 (55.8–65.2) 79.1 (76.1–82.1) 88.5 (85.5–91.4)
Obesity  
(BMI ≥ 30)
Men 18.3 (11.9–24.6) 29.1 (23.1–35.1) 38.7 (33.0–44.4) 37.2 (28.7–45.6)
Women 9.2 (5.2–13.1) 28.0 (24.0–31.9) 50.0 (46.3–53.8) 57.7 (53.4–62.0)
Raised blood pressure 
(or on medication)
Men 16.7 (10.3–23.1) 32.7 (26.4–39.1) 48.3 (43.1–53.4) 71.2 (64.0 –78.3)
Women 7.0 (4.3–9.7) 19.6 (16.3–22.8) 54.4 (50.8–57.9) 74.5 (70.8–78.2)
Raised blood pressure 
(NOT on medication)
Men 15.4 (9.2–21.6) 26.6 (20.6–32.6) 35.7 (30.2–41.2) 54.6 (44.2–65.0)
Women 5.8 (3.5–8.2) 15.3 (12.1–18.5) 36.3 (32.0–40.5) 46.4 (40.4–52.4)
Raised blood glucose  
(or on medication)
Men 0.3 (0.0–0.8) 1.9 (0.0–3.9) 10.4 (7.0–13.9) 7.3 (4.3–10.4)
Women 0.0 (0.0–0.0) 1.6 (0.6–2.6) 6.8 (4.9–8.7) 10.2 (7.4–13.1)
Raised cholesterol 
(or on medication)
Men 8.4 (2.7–14.1) 22.9 (16.2–29.5) 30.6 (24.8–36.4) 26.5 (20.2–32.7)
Women 9.9 (5.8–14.1) 23.9 (19.6–28.2) 46.9 (42.9–50.8) 55.0 (50.1–59.9)
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Country Risk factor
Aged 25–34
% (CI 95%)
Aged 35–44 
% (CI 95%)
Aged 45–54 
% (CI 95%)
Aged 55–64 
% (CI 95%)
Kyrgyzstan
Overweight  
(BMI ≥ 25)
Men 35.2 (26.2–44.2) 52.5 (43.3–61.7) 61.8 (53.9–69.7) 66.0 (54.9–77.0)
Women 42.7 (35.3–50.0) 65.9 (60.2–71.5) 79.3 (74.9–83.8) 81.2 (76.0–86.4)
Obesity  
(BMI ≥ 30)
Men 7.8 (3.8–11.8) 18.7 (12.8–24.6) 26.3 (20.2–32.4) 30.4 (21.7–39.2)
Women 12.2 (8.0–16.4) 28.0 (22.4–33.6) 39.1 (33.0–45.2) 50.7 (45.1–56.4)
Raised blood pressure 
(or on medication)
Men 26.1 (18.5–33.6) 39.0 (30.4–47.7) 59.0 (50.8–67.2) 71.9 (63.2–80.7)
Women 18.4 (14.0–22.9) 40.4 (34.6–46.2) 63.9 (58.8–69.0) 75.4 (65.7–85.1)
Raised blood pressure 
(NOT on medication)
Men 25.8 (18.2–33.4) 37.8 (29.1–46.6) 54.4 (45.5–63.2) 62.8 (51.9–73.8)
Women 18.1 (13.7–22.5) 36.8 (30.8–42.8) 54.2 (48.0–60.3) 62.8 (51.2–74.4)
Raised blood glucose  
(or on medication)
Men 2.1 (0.5–3.8) 5.6 (2.3–9.0) 13.3 (7.9–18.7) 14.1 (8.3–20.0)
Women 4.9 (1.9–7.8) 9.5 (5.8–13.2) 14.7 (9.9–19.5) 19.0 (14.8–23.2)
Raised cholesterol 
(or on medication)
Men 7.2 (3.2–11.1) 19.6 (14.0–25.2) 29.8 (21.2–38.4) 24.2 (17.0–31.5)
Women 22.0 (15.7–28.3) 23.5 (18.8–28.1) 34.9 (29.3–40.6) 49.9 (38.0–61.8)
Aged 18–29
% (CI 95%)
Aged 30–44 
% (CI 95%)
Aged 45–59 
% (CI 95%)
Aged 60–69 
% (CI 95%)
Republic of 
Moldova
Overweight  
(BMI ≥ 25)
Men 39.6 (33.0–46.2) 63.0 (57.6–68.3) 66.8 (62.6–71.1) 67.5 (61.8–73.2)
Women 25.0 (20.5–29.6) 53.5 (48.8–58.1) 79.8 (76.9–82.7) 85.2 (81.8–88.6)
Obesity  
(BMI ≥ 30)
Men 5.5 (3.0–8.0) 19.8 (15.5–24.1) 26.1 (22.2–29.9) 36.2 (30.3–42.1)
Women 9.5 (5.9–13.1) 23.0 (19.2–26.8) 45.7 (42.1–49.4) 50.4 (45.8–54.9)
Raised blood pressure 
(or on medication)
Men 20.6 (14.9–26.2) 38.0 (32.4–43.5) 58.2 (53.3–63.2) 72.2 (66.2–78.2)
Women 12.7 (8.5–16.9) 28.6 (24.8–32.4) 63.7 (60.0–67.4) 81.3 (77.6–85.0)
Raised blood pressure 
(NOT on medication)
Men 20.4 (14.8–26.0) 35.7 (30.1–41.3) 52.1 (46.7–57.5) 61.5 (53.8–69.1)
Women 10.9 (7.0–14.9) 25.9 (22.2–29.6) 52.6 (47.9–57.3) 65.8 (60.0–71.6)
Raised blood glucose  
(or on medication)
Men 6.1 (2.2–9.9) 10.4 (7.0–13.9) 15.7 (12.1–19.4) 20.5 (15.0–25.9)
Women 4.5 (2.2–6.9) 10.8 (8.2–13.5) 19.5 (16.4–22.6) 25.9 (21.5–30.3)
Raised cholesterol 
(or on medication)
Men 15.5 (9.7–21.4) 27.4 (22.3–32.5) 35.3 (30.0–40.5) 37.7 (30.7–44.7)
Women 20.0 (15.1–24.9) 26.7 (22.7–30.7) 42.3 (38.0–46.6) 52.8 (47.5–58.2)
Aged 15–29
% (CI 95%)
Aged 30–44 
% (CI 95%)
Aged 45–59 
% (CI 95%)
Aged 60–69 
% (CI 95%)
Turkey
Overweight  
(BMI ≥ 25)
Men 38.2 (33.2–43.1) 70.6 (66.0–75.2) 76.5 (72.0–81.0) 83.6 (79.3–88.0)
Women 33.5 (28.9–38.1) 66.8 (62.5–71.2) 90.1 (87.6–92.5) 91.9 (88.6–95.2)
Obesity  
(BMI ≥ 30)
Men 8.0 (4.8–11.1) 19.7 (15.9–23.5) 32.5 (28.0–36.9) 40.6 (34.3–46.9)
Women 9.9 (7.4–12.4) 30.1 (26.5–33.7) 55.9 (51.2–60.5) 66.9 (61.3–72.4)
Raised blood pressure 
(or on medication)
Men 12.5 (8.1–16.9) 16.3 (12.7–20.0) 36.6 (32.0–41.2) 54.8 (48.6–61.1)
Women 9.8 (6.3–13.2) 16.3 (13.3–19.2) 41.8 (37.3–46.4) 61.9 (55.9–67.8)
Raised blood pressure 
(NOT on medication)
Men 11.0 (6.8–15.3) 14.1 (10.8–17.5) 27.0 (22.3–31.7) 36.3 (29.0–43.6)
Women 8.9 (5.5–12.3) 12.5 (10.0–15.1) 24.8 (20.7–28.9) 37.2 (30.2–44.1)
Raised blood glucose  
(or on medication)
Men 2.1 (0.1–4.2) 7.8 (3.0–12.6) 14.5 (9.3–19.8) 30.6 (21.3–39.9)
Women 0.9 (0.0–2.2) 8.9 (4.7–13.2) 18.4 (12.1–24.8) 21.8 (14.9–28.7)
Raised cholesterol 
(or on medication)
Men 8.8 (4.3–13.3) 21.8 (15.1–28.4) 28.2 (21.1–35.4) 34.1 (25.4–42.8)
Women 5.8 (2.8–8.8) 22.5 (16.5–28.5) 50.9 (43.3–58.5) 51.3 (43.0–59.7)
Aged 18–29
% (CI 95%)
Aged 30–44 
% (CI 95%)
Aged 45–59 
% (CI 95%)
Aged 60–69 
% (CI 95%)
Ukraine
Overweight  
(BMI ≥ 25)
Men 40.9 (32.1–49.7) 51.6 (36.1–67.0) 75.1 (68.4–81.9) 66.6 (59.5–73.6)
Women 31.8 (21.3–42.3) 52.8 (47.2–58.4) 76.4 (71.6–81.3) 77.5 (72.5–82.4)
Obesity  
(BMI ≥ 30)
Men 6.6 (0.5–12.8) 14.0 (8.4–19.7) 34.6 (24.8–44.5) 28.2 (21.8–34.5)
Women 13.6 (4.5–22.6) 23.0 (17.1–28.9) 37.8 (32.8–42.8) 46.4 (40.7–52.0)
Raised blood pressure 
(or on medication)
Men 15.9 (8.6–23.1) 20.4 (12.6–28.1) 53.3 (44.4–62.2) 68.3 (61.9–74.8)
Women 9.5 (2.8–16.2) 20.5 (15.8–25.3) 47.7 (41.9–53.5) 73.1 (67.6–78.7)
Raised blood pressure 
(NOT on medication)
Men 13.9 (7.2–20.7) 17.6 (10.6–24.7) 49.1 (39.7–58.5) 59.1 (52.2–66.1)
Women 9.0 (2.4–15.7) 17.2 (12.6–21.8) 39.0 (33.3–44.7) 58.0 (52.0–64.0)
Raised blood glucose  
(or on medication)
Men 3.7 (0.6–6.8) 3.7 (1.3–6.2) 9.2 (4.8–13.6) 14.6 (8.5–20.8)
Women 2.7 (0.0–5.4) 4.6 (1.9–7.4) 6.1 (3.8–8.4) 20.2 (15.1–25.4)
Raised cholesterol 
(or on medication)
Men 21.3 (13.1–29.6) 35.2 (26.6–43.8) 56.7 (46.6–66.7) 46.9 (38.8–55.0)
Women 22.4 (12.5–32.3) 31.0 (24.2–37.7) 53.8 (48.1–59.4) 57.7 (51.2–64.3)
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Country Risk factor
Aged 25–34
% (CI 95%)
Aged 35–44 
% (CI 95%)
Aged 45–54 
% (CI 95%)
Uzbekistan
Overweight  
(BMI ≥ 25)
Men 38.0 (28.1–47.9) 63.4 (58.0–68.8) 73.2 (69.7–76.7)
Women 29.7 (23.2–36.1) 63.1 (59.1–67.2) 83.2 (80.7–85.6)
Obesity  
(BMI ≥ 30)
Men 11.8 (6.1–17.6) 21.9 (17.0–26.8) 35.4 (30.5–40.3)
Women 7.1 (3.6–10.7) 24.9 (21.2–28.7) 47.1 (43.0–51.2)
Raised blood pressure 
(or on medication)
Men 26.6 (17.8–35.4) 36.9 (30.7–43.0) 59.8 (55.7–63.8)
Women 22.3 (15.5–29.2) 34.3 (29.5–39.2) 60.2 (55.8–64.6)
Raised blood pressure 
(NOT on medication)
Men 18.0 (10.7–25.4) 30.4 (24.9–36.0) 47.6 (43.1–52.1)
Women 11.7 (5.8–17.6) 19.7 (15.8–23.5) 45.0 (41.1–48.8)
Raised blood glucose  
(or on medication)
Men 4.1 (1.0–7.2) 5.8 (3.4–8.2) 18.1 (15.4–20.9)
Women 3.2 (1.1–5.3) 6.6 (4.2–9.0) 16.0 (13.1–18.9)
Raised cholesterol 
(or on medication)
Men 5.8 (1.5–10.2) 9.5 (5.7–13.3) 17.8 (14.7–21.0)
Women 6.3 (2.9–9.8) 11.0 (8.6–13.3) 26.5 (23.7–29.4)
 CI: confidence interval.
Table A1.7. Prevalence of behavioural risk factors by geographic location
Country Risk factor
Rural
% (CI 95%)
Urban 
% (CI 95%)
Belarus
Current tobacco use
Men 54.1 (49.4–58.8) 43.3 (39.8–46.7)
Women 11.7 (9.4–14.0) 13.2 (11.3–15.2)
Alcohol
Men 63.8 (59.5–68.2) 65.9 (60.9–71.0)
Women 35.4 (30.6–40.1) 46.7 (42.6–50.9)
Alcohol  
(heavy episodic)
Men 35.9 (31.1–40.6) 34.1 (29.9–38.4)
Women 7.7 (5.5–9.9) 6.3 (4.8–7.8)
Unhealthy diet  
(< 5 fruit/veg)
Men 77.3 (71.6–83.0) 78.4 (73.9–83.0)
Women 66.5 (60.4–72.6) 69.8 (65.4–74.2)
Unhealthy diet  
(add salt)
Men 39.0 (33.7–44.2) 33.0 (27.3–38.8)
Women 33.5 (28.0–39.0) 23.6 (19.3–28.0)
Unhealthy diet 
(processed foods)
Men 47.6 (43.3–51.9) 40.0 (35.6–44.5)
Women 32.0 (27.8–36.2) 25.7 (22.5–28.9)
Insufficient physical 
activity
Men 11.0 (8.2–13.8) 14.4 (11.4–17.4)
Women 13.6 (10.3–16.9) 13.4 (10.9–15.8)
Georgia
Current tobacco use
Men 55.6 (50.2–61.0) 58.6 (54.3–62.9)
Women 3.2 (2.0–4.4) 10.6 (8.6–12.7)
Alcohol
Men 61.5 (56.2–66.8) 56.2 (51.3–61.0)
Women 18.1 (15.1–21.2) 23.1 (20.1–26.1)
Alcohol  
(heavy episodic)
Men 38.5 (32.2–44.8) 32.0 (26.8–37.2)
Women 2.8 (1.4–4.2) 2.4 (1.3–3.5)
Unhealthy diet  
(< 5 fruit/veg)
Men 58.1 (51.8–64.4) 69.7 (64.6–74.7)
Women 58.8 (54.4–63.2) 65.7 (61.9–69.4)
Unhealthy diet  
(add salt)
Men 32.8 (26.2–39.4) 33.9 (29.6–38.3)
Women 20.9 (17.8–23.9) 20.4 (17.8–23.1)
Unhealthy diet 
(processed foods)
Men 17.1 (11.0–23.3) 20.8 (17.0–24.5)
Women 9.1 (7.1–11.1) 11.0 (9.0–13.0)
Insufficient physical 
activity
Men 11.4 (8.2–14.7) 21.4 (17.4–25.4)
Women 14.9 (12.1–17.6) 21.5 (18.7–24.4)
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Country Risk factor
Rural
% (CI 95%)
Urban 
% (CI 95%)
Kyrgyzstan
Current tobacco use
Men 53.8 (46.4–61.2) 45.6 (40.2–51.1)
Women 4.7 (2.7–6.8) 1.5 (0.7–2.4)
Alcohol
Men 56.3 (39.8–72.8) 39.4 (33.8–45.1)
Women 21.9 (15.5–28.3) 15.3 (11.7–19.0)
Alcohol  
(heavy episodic)
Men 34.3 (25.5–43.1) 17.5 (13.7–21.2)
Women 2.0 (0.6–3.4) 3.2 (1.7–4.6)
Unhealthy diet  
(< 5 fruit/veg)
Men 75.1 (64.8–85.4) 77.5 (71.0–84.0)
Women 71.6 (61.3–81.9) 70.8 (64.5–77.2)
Unhealthy diet  
(add salt)
Men 13.2 (5.8–20.7) 23.6 (16.6–30.7)
Women 11.1 (7.1–15.0) 18.3 (12.9–23.6)
Unhealthy diet 
(processed foods)
Men 30.4 (19.6–41.3) 27.6 (21.9–33.3)
Women 24.0 (18.3–29.6) 26.1 (21.4–30.7)
Insufficient physical 
activity
Men 11.4 (4.9–17.8) 7.7 (5.3–10.1)
Women 19.2 (15.1–23.4) 11.1 (8.4–13.9)
Republic of 
Moldova
Current tobacco use
Men 44.3 (39.7–48.9) 42.9 (39.0–46.7)
Women 1.3 (0.3–2.2) 10.4 (8.4–12.5)
Alcohol
Men 71.6 (66.6–76.5) 67.7 (63.0–72.4)
Women 56.6 (52.3–61.0) 50.0 (46.2–53.7)
Alcohol  
(heavy episodic)
Men 32.1 (26.8–37.4) 25.3 (20.8–29.8)
Women 10.5 (7.8–13.1) 7.9 (5.9–9.9)
Unhealthy diet  
(< 5 fruit/veg)
Men 63.0 (51.1–68.8) 69.1 (65.0–73.3)
Women 66.7 (62.1–71.3) 68.4 (64.6–72.3)
Unhealthy diet  
(add salt)
Men 26.4 (22.2–30.6) 29.8 (24.8–34.8)
Women 20.2 (17.3–23.2) 20.4 (17.0–23.7)
Unhealthy diet 
(processed foods)
Men 32.0 (27.5–36.4) 41.7 (37.0–46.5)
Women 25.8 (21.6–30.0) 30.6 (27.4–33.7)
Insufficient physical 
activity
Men 9.3 (5.8–12.8) 12.1 (9.5–14.8)
Women 8.0 (5.3–10.6) 11.0 (8.9–13.1)
Turkey
Current tobacco use
Men 46.3 (41.0–51.5) 42.6 (39.6–45.6)
Women 11.0 (7.8–14.3) 21.8 (19.3–24.3)
Alcohol
Men 11.7 (7.6–15.8) 13.5 (11.4–15.7)
Women 1.7 (0.0–3.4) 3.4 (2.3–4.4)
Alcohol  
(heavy episodic)
Men 9.3 (5.4–13.1) 8.5 (6.7–10.3)
Women 1.6 (0.0–3.2) 1.9 (1.0–2.8)
Unhealthy diet  
(< 5 fruit/veg)
Men 86.1 (82.2–90.1) 88.3 (85.9–90.6)
Women 84.6 (80.9–88.4) 88.7 (86.9–90.5)
Unhealthy diet  
(add salt)
Men 32.1 (26.3–37.9) 28.5 (25.5–31.4)
Women 31.9 (26.7–37.1) 25.6 (23.1–28.0)
Unhealthy diet 
(processed foods)
Men 22.8 (18.1–27.6) 29.3 (26.4–32.2)
Women 15.7 (11.4–20.0) 25.2 (22.5–27.8)
Insufficient physical 
activity
Men 24.9 (20.7–29.2) 35.5 (32.5–38.5)
Women 46.6 (41.9–51.3) 55.7 (53.0–58.4)
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Country Risk factor
Rural
% (CI 95%)
Urban 
% (CI 95%)
Ukraine
Current tobacco use
Men 53.8 (48.5–59.1) 48.6 (39.2–58.1)
Women 11.3 (7.8–14.7) 20.4 (17.2–23.6)
Alcohol
Men 65.8 (59.2–72.3) 66.3 (59.2–73.5)
Women 37.8 (32.0–43.6) 49.1 (44.8–53.3)
Alcohol  
(heavy episodic)
Men 31.9 (24.7–39.1) 28.3 (15.4–41.3)
Women 10.1 (5.8–14.3) 9.0 (6.6–11.3)
Unhealthy diet  
(< 5 fruit/veg)
Men 67.1 (58.1–76.1) 76.3 (70.1–82.5)
Women 58.2 (51.4–65.1) 60.3 (55.2–65.4)
Unhealthy diet  
(add salt)
Men 48.4 (41.1–55.7) 55.3 (46.3–64.3)
Women 37.3 (30.7–44.0) 35.8 (31.1–40.6)
Unhealthy diet 
(processed foods)
Men 32.7 (24.9–40.4) 32.5 (25.3–39.7)
Women 20.7 (15.5–25.8) 21.5 (17.9–25.0)
Insufficient physical 
activity
Men 6.6 (3.3–10.0) 10.4 (6.8–13.9)
Women 7.4 (4.5–10.3) 13.1 (9.4–16.9)
Uzbekistan
Current tobacco use
Men 17.8 (13.9–21.6) 21.4 (14.1–28.7)
Women 0.4 (0.0–0.7) 0.9 (0.0–1.8)
Alcohol
Men 8.6 (5.2–12.0) 8.8 (6.1–11.6)
Women 0.3 (0.1–0.5) 2.0 (0.3–3.6)
Alcohol  
(heavy episodic)
Men 2.8 (1.5–4.0) 2.5 (0.3–4.7)
Women 0.1 (0.0–0.1) 0.6 (0.0–1.4)
Unhealthy diet  
(< 5 fruit/veg)
Men 14.2 (10.4–18.0) 16.2 (8.7–23.6)
Women 17.7 (14.3–21.2) 16.1 (9.8–22.5)
Unhealthy diet  
(add salt)
Men 38.4 (31.8–44.9) 24.0 (15.7–32.3)
Women 43.3 (37.8–48.7) 28.6 (21.1–36.1)
Unhealthy diet 
(processed foods)
Men 38.1 (30.6–45.6) 23.4 (14.2–32.7)
Women 43.4 (38.4–48.4) 26.9 (19.4–34.5)
Insufficient physical 
activity
Men 18.0 (13.6–22.4) 27.3 (19.6–34.9)
Women 29.8 (25.3–34.3) 34.4 (25.5–43.4)
 CI: confidence interval.
Table A1.8. Prevalence of biological risk factors by geographic location
Country Risk factor
Rural
% (CI 95%)
Urban 
% (CI 95%)
Belarus
Overweight  
(BMI ≥ 25)
Men 57.0 (53.1–60.8) 65.5 (61.6–69.4)
Women 65.1 (61.3–68.8) 55.9 (52.5–59.3)
Obesity  
(BMI ≥ 30)
Men 20.0 (16.9–23.1) 20.3 (17.1–23.4)
Women 35.7 (32.2–39.2) 26.0 (23.0–29.0)
Raised blood pressure 
(or on medication)
Men 50.6 (46.3–54.9) 41.1 (37.2–45.1)
Women 49.8 (46.2–53.3) 39.9 (36.8–43.0)
Raised blood pressure 
(NOT on medication)
Men 40.9 (36.2–45.6) 30.2 (26.2–34.2)
Women 30.7 (26.7–34.7) 21.2 (18.3–24.2)
Raised blood glucose  
(or on medication)
Men 2.8 (1.7–3.8) 3.6 (2.1–5.0)
Women 4.2 (2.6–5.9) 3.7 (2.4–5.0)
Raised cholesterol 
(or on medication)
Men 32.3 (28.1–36.5) 34.5 (30.8–38.1)
Women 41.9 (37.9–46.0) 43.2 (39.8–46.5)
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Country Risk factor
Rural
% (CI 95%)
Urban 
% (CI 95%)
Georgia
Overweight  
(BMI ≥ 25)
Men 61.4 (54.9–68.0) 69.7 (65.2–74.2)
Women 67.1 (63.6–70.6) 60.7 (57.4–64.1)
Obesity  
(BMI ≥ 30)
Men 28.3 (23.2–33.5) 32.2 (28.1–36.3)
Women 38.4 (35.0–41.8) 33.7 (30.8–36.7)
Raised blood pressure 
(or on medication)
Men 39.6 (34.5–44.7) 37.6 (32.7–42.5)
Women 40.8 (37.5–44.1) 33.3 (30.3–36.4)
Raised blood pressure 
(NOT on medication)
Men 30.2 (25.3–35.2) 27.2 (22.2–32.1)
Women 26.0 (22.8–29.3) 17.5 (14.7–20.4)
Raised blood glucose  
(or on medication)
Men 4.7 (3.1–6.4) 4.8 (2.7–6.9)
Women 4.2 (2.9–5.5) 4.4 (3.2–5.6)
Raised cholesterol 
(or on medication)
Men 19.8 (15.0–24.6) 24.2 (19.3–29.2)
Women 32.0 (28.0–36.1) 33.9 (30.5–37.4)
Kyrgyzstan
Overweight  
(BMI ≥ 25)
Men 48.7 (30.3–67.1) 49.7 (44.2–55.3)
Women 64.6 (58.6–70.6) 62.9 (59.1–66.7)
Obesity  
(BMI ≥ 30)
Men 18.8 (12.8–24.8) 17.1 (13.2–21.0)
Women 28.2 (23.0–33.3) 29.5 (26.2–32.8)
Raised blood pressure 
(or on medication)
Men 43.4 (34.1–52.7) 42.4 (37.0–47.8)
Women 37.1 (31.4–42.7) 46.5 (42.7–50.2)
Raised blood pressure 
(NOT on medication)
Men 40.6 (31.8–49.4) 38.2 (32.6–43.8)
Women 29.7 (24.7–34.6) 38.8 (34.9–42.7)
Raised blood glucose  
(or on medication)
Men 6.9 (4.4–9.4) 4.3 (2.6–6.1)
Women 4.6 (2.6–6.5) 5.3 (3.3–7.4)
Raised cholesterol 
(or on medication)
Men 18.2 (13.3–23.1) 17.2 (13.6–20.8)
Women 34.8 (25.0–44.6) 27.0 (23.7–30.3)
Republic of 
Moldova
Overweight  
(BMI ≥ 25)
Men 52.4 (47.7–57.1) 60.4 (55.5–65.2)
Women 62.4 (58.8–66.0) 48.6 (44.5–52.6)
Obesity  
(BMI ≥ 30)
Men 16.4 (13.5–19.2) 19.5 (16.1–22.9)
Women 33.5 (30.4–36.7) 22.9 (20.1–25.7)
Raised blood pressure 
(or on medication)
Men 44.7 (39.6–49.7) 35.3 (31.2–39.4)
Women 46.7 (42.8–50.5) 31.5 (27.9–35.1)
Raised blood pressure 
(NOT on medication)
Men 40.8 (35.5–46.1) 30.1 (26.0–34.2)
Women 37.9 (33.7–42.0) 21.9 (18.6–25.3)
Raised blood glucose  
(or on medication)
Men 10.6 (7.9–13.3) 12.7 (9.9–15.5)
Women 13.4 (11.2–15.7) 12.5 (10.2–14.8)
Raised cholesterol 
(or on medication)
Men 28.4 (23.9–33.0) 24.3 (20.2–28.4)
Women 32.3 (28.5–36.0) 31.8 (27.9–35.7)
Turkey
Overweight  
(BMI ≥ 25)
Men 67.5 (62.6–72.3) 61.4 (58.4–64.4)
Women 72.3 (67.8–76.8) 64.5 (61.7–67.2)
Obesity  
(BMI ≥ 30)
Men 28.5 (23.8–33.1) 19.6 (17.2–22.0)
Women 44.0 (39.3–48.7) 33.9 (31.6–36.3)
Raised blood pressure 
(or on medication)
Men 33.6 (28.8–38.3) 23.8 (21.0–26.6)
Women 40.1 (35.4–44.7) 26.6 (24.2–29.1)
Raised blood pressure 
(NOT on medication)
Men 24.6 (20.0–29.1) 16.8 (14.1–19.6)
Women 24.2 (20.1–28.3) 15.8 (13.5–18.0)
Raised blood glucose  
(or on medication)
Men 12.3 (8.1–16.4) 10.2 (7.4–13.0)
Women 13.3 (9.5–17.1) 11.1 (8.2–13.9)
Raised cholesterol 
(or on medication)
Men 19.0 (12.9–25.2) 21.4 (17.6–25.1)
Women 28.2 (21.4–35.0) 28.6 (24.6–32.5)
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Country Risk factor
Rural
% (CI 95%)
Urban 
% (CI 95%)
Ukraine
Overweight  
(BMI ≥ 25)
Men 60.7 (54.3–67.2) 56.6 (45.9–67.2)
Women 66.9 (62.1–71.8) 55.4 (51.3–59.6)
Obesity  
(BMI ≥ 30)
Men 22.1 (16.6–27.6) 19.2 (12.8–25.5)
Women 35.9 (30.0–41.8) 25.4 (21.7–29.2)
Raised blood pressure 
(or on medication)
Men 36.3 (29.6–43.0) 33.7 (25.7–41.6)
Women 40.9 (34.9–46.8) 30.9 (27.1–34.6)
Raised blood pressure 
(NOT on medication)
Men 24.5 (17.8–31.1) 24.1 (16.3–31.9)
Women 23.4 (16.4–30.3) 15.1 (11.8–18.3)
Raised blood glucose  
(or on medication)
Men 6.4 (3.3–9.5) 6.9 (4.3–9.6)
Women 7.8 (5.1–10.4) 7.1 (5.2–9.0)
Raised cholesterol 
(or on medication)
Men 41.4 (33.0–49.8) 40.1 (32.6–47.5)
Women 41.2 (32.7–49.6) 40.0 (32.6–47.4)
Uzbekistan
Overweight  
(BMI ≥ 25)
Men 55.9 (50.1–61.7) 54.8 (46.4–63.2)
Women 59.1 (55.0–63.3) 53.0 (47.0–59.1)
Obesity  
(BMI ≥ 30)
Men 24.3 (19.7–29.0) 13.9 (9.1–18.7)
Women 28.2 (25.0–31.5) 19.3 (14.9–23.7)
Raised blood pressure 
(or on medication)
Men 37.9 (31.9–43.9) 40.1 (30.3–49.8)
Women 42.8 (37.6–47.9) 25.9 (19.4–32.4)
Raised blood pressure 
(NOT on medication)
Men 26.6 (22.1–31.1) 30.6 (20.2–41.0)
Women 21.7 (16.7–26.7) 13.7 (9.5–18.0)
Raised blood glucose  
(or on medication)
Men 8.3 (6.2–10.4) 9.4 (5.7–13.1)
Women 9.5 (7.6–11.3) 5.3 (2.9–7.8)
Raised cholesterol 
(or on medication)
Men 8.8 (6.2–11.4) 14.6 (9.5–19.8)
Women 13.5 (11.2–15.8) 15.3 (11.8–18.9)
 CI: confidence interval.
Table A1.9. Education level for analysis (STEPS survey categories and ISCED levels)
Country Education level for analysis STEPS survey categories ISCED levels
Armenia
Low level of education
1 = no formal schooling
2 = less than primary school 
3 = primary school completed
4 = secondary school completed
ISCED 0–2
Medium level of education 5 = high school completed ISCED 3–5
High level of education 6 = college/university completed7 = postgraduate degree ISCED 6–8
Belarus
Low level of education
1 = no formal schooling
2 = primary school completed
3 = secondary school completed
ISCED 0–2
Medium level of education 4 = college completed5 = high school completed ISCED 3–5
High level of education 6 = university completed7 = postgraduate degree ISCED 6–8
Georgia
Low level of education
1 = no formal schooling
2 = primary school completed
3 = main secondary school completed
ISCED 0–2
Medium level of education 4 = secondary school completed5 = professional education completed ISCED 3–5
High level of education 6 = university completed7 = postgraduate degree ISCED 6–8
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Country Education level for analysis STEPS survey categories ISCED levels
Kyrgyzstan
Low level of education
1 = no formal schooling
2 = primary school completed
3 = secondary school not fully completed
4 = secondary school completed
ISCED 0–3
Medium level of education 5 = secondary technical ISCED 4–5
High level of education 6 = college/university completed7 = candidate of medical sciences ISCED 6–8
Republic of 
Moldova
Low level of education
1 = no formal schooling/less than primary school
2 = primary school completed
3 = gymnasium completed
4 = lyceum/secondary school completed
ISCED 0–3
Medium level of education 5 = college/vocational school completed ISCED 4–5
High level of education 6 = university completed/postgraduate degree ISCED 6–8
Turkey
Low level of education
1 = illiterate
2 = literate, but not completed formal school
3 = primary school completed
ISCED 0–2
Medium level of education 4 = secondary or vocational secondary completed5 = high school or vocational high school completed ISCED 3–4
High level of education
6 = 2- or 3-year college completed
7 = 4-year college or faculty completed
8 = master’s degree completed
9 = doctoral degree completed
ISCED 5–8
Ukraine
Low level of education
1 = no formal schooling
2 = less than primary school 
3 = primary school completed
4 = secondary school completed
ISCED 0–3
Medium level of education 5 = high school completed6 = special secondary completed ISCED 4–5
High level of education 7 = college/university completed8 = postgraduate degree ISCED 6–8
Uzbekistan
Low level of education
1 = no formal schooling
2 = less than primary school
3 = primary school completed
ISCED 0–1
Medium level of education 4 = secondary school completed5 = secondary professional (college) ISCED 3–4
High level of education
6 = university degree (bachelor)/associate of science
7 = postgraduate degree (master’s degree, doctoral
 degree)
ISCED 5–8
ISCED: International Standard Classification of Education.
Table A1.10. Prevalence of behavioural risk factors by education level
Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Armenia
Current tobacco use
Men 52.5 (47.2–57.7) 53.7 (45.5–61.9) 47.4 (38.6–56.2)
Women 1.6 (0.6–2.6) 1.5 (0.5–2.5) 2.5 (0.8–4.2)
Alcohol
Men 43.5 (36.4–50.7) 54.9 (45.6–64.1) 43.5 (33.5–53.4)
Women 17.2 (13.3–21.1) 23.9 (19.0–28.9) 25.9 (19.9–31.8)
Alcohol  
(heavy episodic)
Men 10.7 (6.6–14.7) 11.4 (6.5–16.2) 11.7 (6.1–17.3)
Women 0.0 (0.0–0.0) 0.3 (0.0–0.6) 0.3 (0.0–0.8)
Unhealthy diet  
(< 5 fruit/veg)
Men 79.2 (73.7–84.7) 74.9 (66.5–83.4) 79.6 (72.2–87.1)
Women 77.7 (73.4–82.0) 69.9 (64.7–75.1) 70.6 (64.1–77.1)
Unhealthy diet  
(add salt)
Men 39.6 (33.7–45.6) 39.6 (31.5–47.8) 42.2 (33.5–50.8)
Women 31.3 (26.7–35.9) 31.0 (26.0–36.0) 27.1 (21.6–32.5)
Unhealthy diet 
(processed foods)
Men 32.6 (26.7–38.5) 34.5 (26.4–42.5) 37.8 (30.0–45.5)
Women 28.2 (23.7–32.7) 28.1 (22.9–33.2) 26.7 (21.2–32.2)
Insufficient physical 
activity
Men 24.7 (18.8–30.6) 16.6 (11.0–22.3) 21.3 (13.4–29.2)
Women 23.9 (19.5–28.2) 19.1 (14.4–23.7) 16.1 (10.9–21.4)
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Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Belarus
Current tobacco use
Men 49.4 (44.1–54.6) 53.7 (50.2–57.2) 32.1 (26.8–37.3)
Women 16.0 (12.0–20.0) 13.3 (11.4–15.2) 9.2 (6.9–11.5)
Alcohol
Men 56.1 (50.5–61.7) 68.4 (64.3–72.5) 65.2 (59.1–71.3)
Women 33.8 (28.0–39.7) 42.2 (38.5–45.8) 46.1 (41.4–50.8)
Alcohol  
(heavy episodic)
Men 31.1 (25.7–36.6) 38.1 (34.1–42.2) 30.3 (24.7–35.8)
Women 10.2 (6.9–13.5) 7.1 (5.3–9.0) 4.5 (2.8–6.2)
Unhealthy diet  
(< 5 fruit/veg)
Men 75.4 (69.4–81.4) 79.3 (75.4–83.2) 76.8 (71.2–82.4)
Women 71.2 (65.7–76.6) 68.3 (63.9–72.8) 66.6 (61.9–71.3)
Unhealthy diet  
(add salt)
Men 40.7 (34.9–46.6) 35.4 (30.7–40.0) 31.6 (25.8–37.3)
Women 35.8 (29.7–41.9) 28.3 (24.0–32.6) 22.5 (17.9–27.1)
Unhealthy diet 
(processed foods)
Men 42.8 (36.4–49.1) 45.8 (41.7–49.9) 38.1 (32.3–43.9)
Women 28.8 (23.6–34.0) 30.2 (26.7–33.7) 25.4 (21.5–29.3)
Insufficient physical 
activity
Men 12.6 (9.0–16.1) 10.5 (8.2–12.8) 19.7 (15.1–24.3)
Women 16.4 (11.4–21.4) 10.7 (8.6–12.7) 16.1 (12.7–19.5)
Georgia
Current tobacco use
Men 57.4 (50.8–63.9) 57.9 (53.1–62.7) 55.1 (49.1–61.2)
Women 6.1 (4.0–8.2) 6.3 (4.6–8.1) 9.9 (7.4–12.4)
Alcohol
Men 52.6 (45.0–60.2) 59.1 (54.2–64.1) 64.6 (58.5–70.8)
Women 15.4 (12.2–18.5) 23.1 (19.8–26.5) 22.4 (18.7–26.1)
Alcohol  
(heavy episodic)
Men 31.8 (24.2–39.4) 35.1 (29.8–40.3) 39.3 (32.5–46.2)
Women 2.6 (1.0–4.3) 3.0 (1.5–4.4) 1.9 (0.5–3.3)
Unhealthy diet  
(< 5 fruit/veg)
Men 67.4 (60.1–74.7) 64.0 (58.4–69.6) 59.6 (53.1–66.2)
Women 62.0 (57.2–66.8) 64.3 (60.4–68.2) 59.1 (54.1–64.1)
Unhealthy diet  
(add salt)
Men 39.9 (33.3–46.5) 34.0 (28.8–39.3) 25.7 (20.3–31.2)
Women 25.7 (21.9–29.5) 19.3 (16.4–22.2) 17.5 (13.9–21.0)
Unhealthy diet 
(processed foods)
Men 20.2 (14.1–26.3) 20.4 (15.1–25.7) 14.9 (10.3–19.5)
Women 12.7 (9.7–15.7) 8.4 (6.3–10.4) 10.4 (7.7–13.1)
Insufficient physical 
activity
Men 15.5 (10.0–21.1) 15.1 (11.2–19.0) 18.9 (13.7–24.2)
Women 20.8 (17.3–24.4) 16.3 (13.3–19.2) 19.6 (15.5–23.7)
Kyrgyzstan
Current tobacco use
Men 43.5 (37.2–49.8) 52.3 (45.8–58.8) 52.9 (44.7–61.1)
Women 1.9 (0.7–3.1) 2.8 (1.1–4.4) 4.7 (2.3–7.1)
Alcohol
Men 43.3 (35.1–51.5) 40.8 (34.3–47.3) 50.9 (35.4–66.5)
Women 14.2 (10.6–17.8) 22.2 (17.0–27.4) 20.6 (14.1–27.1)
Alcohol  
(heavy episodic)
Men 20.6 (15.6–25.6) 22.1 (16.5–27.6) 27.3 (17.5–37.0)
Women 2.1 (0.7–3.4) 3.4 (1.7–5.1) 3.5 (1.2–5.8)
Unhealthy diet  
(< 5 fruit/veg)
Men 77.5 (70.5–84.4) 75.7 (68.4–82.9) 76.4 (67.7–85.2)
Women 73.3 (67.1–79.5) 74.2 (67.9–80.5) 60.8 (50.9–70.7)
Unhealthy diet  
(add salt)
Men 22.0 (15.6–28.5) 19.1 (12.9–25.4) 18.5 (7.1–30.0)
Women 15.1 (11.2–19.1) 16.9 (10.9–22.8) 15.1 (8.8–21.4)
Unhealthy diet 
(processed foods)
Men 28.7 (21.1–36.2) 26.5 (18.8–34.3) 29.9 (20.8–39.1)
Women 28.0 (21.8–34.2) 23.2 (18.0–28.5) 21.2 (14.8–27.6)
Insufficient physical 
activity
Men 8.2 (5.4–11.1) 8.5 (4.1–12.9) 10.3 (4.9–15.7)
Women 15.8 (12.0–19.6) 10.5 (7.3–13.6) 14.8 (10.4–19.2)
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Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Republic of 
Moldova
Current tobacco use
Men 47.6 (42.3–52.9) 43.3 (38.5–48.2) 36.1 (30.1–42.1)
Women 5.7 (4.1–7.4) 5.2 (3.3–7.0) 6.0 (4.0–8.0)
Alcohol
Men 68.9 (64.1–73.6) 72.5 (67.9–77.1) 67.7 (60.2–75.2)
Women 55.5 (51.6–59.4) 53.2 (48.7–57.6) 50.2 (44.2–56.1)
Alcohol  
(heavy episodic)
Men 29.6 (24.5–34.8) 30.7 (25.7–35.7) 24.9 (18.0–31.7)
Women 11.7 (8.9–14.5) 8.1 (5.4–10.8) 6.0 (3.7–8.3)
Unhealthy diet  
(< 5 fruit/veg)
Men 69.6 (64.7–74.5) 62.9 (57.2–68.7) 62.6 (56.1–69.0)
Women 72.7 (68.5–76.8) 64.3 (60.0–68.5) 62.2 (56.8–67.6)
Unhealthy diet  
(add salt)
Men 31.3 (26.2–36.4) 27.5 (22.9–32.2) 21.9 (17.0–26.9)
Women 24.0 (20.3–27.7) 17.0 (13.9–20.1) 17.0 (13.0–20.9)
Unhealthy diet 
(processed foods)
Men 35.6 (30.4–40.8) 36.9 (31.6–42.1) 38.0 (31.4–44.6)
Women 27.1 (23.1–31.0) 27.0 (22.7–31.3) 31.0 (26.2–35.8)
Insufficient physical 
activity
Men 9.6 (5.9–13.4) 8.8 (6.3–11.3) 15.6 (11.3–20.0)
Women 9.8 (7.3–12.3) 8.0 (5.9–10.1) 10.8 (7.6–14.0)
Turkey
Current tobacco use
Men 37.4 (33.5–41.4) 46.8 (43.0–50.7) 40.9 (35.0–46.8)
Women 13.7 (11.8–15.6) 23.4 (20.0–26.8) 26.2 (19.0–33.5)
Alcohol
Men 6.8 (5.1–8.6) 13.3 (10.6–15.9) 21.3 (16.3–26.3)
Women 0.4 (0.1–0.7) 4.0 (2.3–5.8) 7.6 (4.4–10.9)
Alcohol  
(heavy episodic)
Men 4.2 (2.9–5.6) 9.3 (6.9–11.6) 12.8 (8.4–17.3)
Women 0.4 (0.1–0.7) 2.7 (1.1–4.3) 3.7 (1.4–5.9)
Unhealthy diet  
(< 5 fruit/veg)
Men 87.8 (84.2–91.4) 88.1 (85.6–90.7) 86.6 (82.4–90.9)
Women 87.7 (85.7–89.7) 87.2 (84.6–89.9) 90.4 (86.8–94.1)
Unhealthy diet  
(add salt)
Men 29.1 (24.6–33.5) 29.8 (26.3–33.4) 28.0 (22.1–34.0)
Women 26.6 (24.0–29.2) 27.9 (24.3–31.4) 24.4 (17.6–31.2)
Unhealthy diet 
(processed foods)
Men 21.4 (17.5–25.3) 29.6 (26.1–33.1) 31.1 (25.3–36.9)
Women 17.3 (15.1–19.6) 27.6 (23.9–31.3) 27.7 (20.6–34.8)
Insufficient physical 
activity
Men 34.0 (30.1–37.8) 32.2 (28.5–36.0) 34.3 (28.8–39.8)
Women 58.7 (56.0–61.4) 52.1 (48.1–56.0) 45.3 (38.4–52.3)
Ukraine
Current tobacco use
Men 72.8 (61.0–84.5) 58.3 (53.3–63.3) 33.3 (21.5–45.2)
Women 23.3 (9.5–37.1) 17.6 (14.4–20.8) 14.1 (10.7–17.5)
Alcohol
Men 67.7 (53.9–81.5) 65.3 (60.1–70.4) 67.6 (56.1–79.1)
Women 56.4 (43.0–69.9) 43.1 (38.7–47.4) 45.3 (39.8–50.8)
Alcohol  
(heavy episodic)
Men 25.1 (11.4–38.9) 28.4 (22.5–34.3) 32.4 (10.6–54.3)
Women 10.6 (4.0–17.2) 10.7 (7.5–13.9) 7.1 (4.3–9.9)
Unhealthy diet  
(< 5 fruit/veg)
Men 78.3 (67.4–89.2) 73.0 (67.9–78.0) 72.8 (61.6–83.9)
Women 57.1 (43.4–70.9) 61.4 (56.2–66.6) 56.4 (50.4–62.3)
Unhealthy diet  
(add salt)
Men 62.9 (48.3–77.5) 50.0 (44.2–55.7) 56.4 (41.1–71.7)
Women 41.9 (28.3–55.6) 38.8 (33.7–43.8) 31.8 (26.3–37.2)
Unhealthy diet 
(processed foods)
Men 20.2 (9.9–30.5) 35.5 (30.5–40.4) 29.8 (18.2–41.4)
Women 17.3 (8.9–25.7) 22.2 (18.7–25.8) 19.7 (15.4–24.0)
Insufficient physical 
activity
Men 6.7 (1.0–12.5) 9.9 (6.9–13.0) 8.1 (3.8–12.4)
Women 12.5 (5.8–19.2) 10.3 (7.4–13.2) 11.2 (6.6–15.7)
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Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Uzbekistan
Current tobacco use
Men 13.5 (5.4–21.7) 19.4 (15.8–23.1) 19.3 (9.0–29.6)
Women 0.9 (0.0–1.9) 0.5 (0.1–0.9) 0.0 (0.0–0.0)
Alcohol
Men 7.6 (0.6–14.6) 9.5 (6.4–12.7) 5.0 (1.6–8.4)
Women 0.1 (0.0–0.2) 1.0 (0.3–1.7) 0.6 (0.0–1.5)
Alcohol  
(heavy episodic)
Men 1.6 (0.1–3.1) 3.1 (1.8–4.5) 0.9 (0.0–2.0)
Women 0.1 (0.0–0.2) 0.3 (0.0–0.6) 0.0 (0.0–0.0)
Unhealthy diet  
(< 5 fruit/veg)
Men 8.2 (2.1–14.2) 16.2 (11.9–20.5) 12.4 (6.6–18.1)
Women 8.4 (5.3–11.5) 19.7 (16.2–23.2) 10.2 (4.2–16.2)
Unhealthy diet  
(add salt)
Men 34.4 (15.6–53.1) 36.3 (30.4–42.1) 24.8 (15.4–34.2)
Women 28.2 (21.5–34.9) 41.6 (36.7–46.5) 30.9 (23.0–38.8)
Unhealthy diet 
(processed foods)
Men 34.6 (16.7–52.5) 35.1 (28.5–41.7) 28.3 (16.7–39.9)
Women 25.7 (19.4–32.0) 41.5 (36.9–46.1) 30.8 (23.0–38.6)
Insufficient physical 
activity
Men 12.1 (5.3–19.0) 19.8 (14.9–24.7) 29.1 (17.9–40.3)
Women 35.3 (26.4–44.2) 29.7 (25.3–34.1) 37.0 (29.6–44.5)
 CI: confidence interval.
Table A1.11. Prevalence of biological risk factors by education level
Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Armenia
Overweight  
(BMI ≥ 25)
Men 39.6 (33.5–45.7) 19.4 (15.8–23.1) 19.3 (9.0–29.6)
Women 54.2 (49.0–59.4) 54.6 (48.6–60.6) 37.0 (31.0–43.0)
Obesity  
(BMI ≥ 30)
Men 11.0 (7.5–14.5) 19.5 (12.4–26.6) 15.6 (9.1–22.1)
Women 28.2 (23.8–32.6) 29.6 (24.8–34.3) 13.6 (9.7–17.6)
Raised blood pressure 
(or on medication)
Men 31.0 (24.7–37.3) 55.7 (45.8–65.7) 42.3 (30.7–54.0)
Women 38.8 (34.3–43.3) 40.1 (35.1–45.1) 27.0 (21.2–32.7)
Raised blood pressure 
(NOT on medication)
Men 26.4 (20.4–32.5) 49.3 (38.5–60.0) 37.0 (25.2–48.8)
Women 30.3 (25.9–34.6) 28.5 (23.5–33.6) 20.2 (14.7–25.8)
Raised blood glucose  
(or on medication)
Men 5.0 (2.2–7.8) 9.2 (3.4–15.1) 7.5 (0.9–14.2)
Women 4.5 (2.7–6.3) 5.1 (2.8–7.5) 4.2 (1.6–6.9)
Raised cholesterol 
(or on medication)
Men 18.0 (11.9–24.2) 30.6 (20.4–40.8) 25.6 (16.3–34.9)
Women 22.7 (18.8–26.5) 32.4 (27.2–37.6) 19.8 (14.5–25.1)
Belarus
Overweight  
(BMI ≥ 25)
Men 53.4 (48.0–58.8) 62.8 (59.2–66.4) 66.8 (61.0–72.6)
Women 61.2 (55.8–66.6) 66.6 (63.4–69.7) 48.3 (43.9–52.6)
Obesity  
(BMI ≥ 30)
Men 19.6 (15.5–23.6) 19.9 (16.9–22.9) 21.5 (16.5–26.6)
Women 35.0 (30.3–39.6) 35.2 (32.2–38.3) 19.2 (16.3–22.1)
Raised blood pressure 
(or on medication)
Men 50.3 (44.6–56.0) 45.4 (41.6–49.1) 40.8 (35.0–46.6)
Women 54.5 (49.0–60.1) 48.4 (45.3–51.5) 31.0 (27.4–34.5)
Raised blood pressure 
(NOT on medication)
Men 40.4 (34.3–46.6) 35.3 (31.4–39.2) 29.3 (23.2–35.4)
Women 32.9 (26.8–39.0) 29.0 (25.9–32.2) 15.9 (12.7–19.1)
Raised blood glucose  
(or on medication)
Men 4.2 (2.4–6.0) 2.8 (1.9–3.8) 2.9 (1.3–4.6)
Women 7.0 (4.0–9.9) 3.8 (2.6–5.0) 2.2 (1.0–3.4)
Raised cholesterol 
(or on medication)
Men 33.0 (27.4–38.6) 33.7 (30.3–37.1) 33.0 (27.9–38.2)
Women 45.0 (39.3–50.7) 43.1 (39.7–46.4) 40.3 (36.2–44.4)
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Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Georgia
Overweight  
(BMI ≥ 25)
Men 63.2 (56.5–69.8) 61.8 (55.9–67.7) 74.7 (68.8–80.6)
Women 72.3 (68.5–76.2) 62.3 (58.6–66.0) 57.0 (51.9–62.1)
Obesity  
(BMI ≥ 30)
Men 24.2 (19.0–29.4) 27.7 (22.8–32.7) 41.0 (34.8–47.1)
Women 45.5 (41.6–49.5) 35.6 (32.0–39.1) 25.8 (22.0–29.5)
Raised blood pressure 
(or on medication)
Men 38.5 (32.1–45.0) 38.0 (32.7–43.2) 39.9 (33.0–46.9)
Women 48.1 (44.2–52.0) 33.3 (30.1–36.5) 30.8 (26.8–34.8)
Raised blood pressure 
(NOT on medication)
Men 29.3 (22.8–35.7) 28.3 (23.0–33.6) 29.0 (22.3–35.8)
Women 27.9 (23.4–32.4) 19.9 (16.9–22.9) 18.4 (14.6–22.2)
Raised blood glucose  
(or on medication)
Men 4.1 (2.0–6.3) 4.3 (2.4–6.2) 6.2 (3.0–9.3)
Women 6.5 (4.4–8.5) 3.6 (2.5–4.8) 3.0 (1.6–4.4)
Raised cholesterol 
(or on medication)
Men 17.7 (12.3–23.1) 22.0 (17.1–26.9) 26.0 (19.4–32.6)
Women 34.1 (29.8–38.4) 32.1 (28.5–35.8) 33.1 (28.0–38.2)
Kyrgyzstan
Overweight  
(BMI ≥ 25)
Men 46.4 (38.9–53.8) 52.9 (45.9–59.9) 51.7 (35.7–67.7)
Women 65.1 (60.6–69.6) 64.9 (59.3–70.5) 57.0 (50.0–64.0)
Obesity  
(BMI ≥ 30)
Men 13.5 (9.7–17.4) 24.4 (18.5–30.3) 18.8 (13.1–24.5)
Women 30.2 (26.2–34.1) 30.0 (25.0–35.0) 24.2 (18.2–30.3)
Raised blood pressure 
(or on medication)
Men 41.2 (35.8–46.6) 49.5 (42.1–57.0) 39.4 (30.9–47.8)
Women 44.5 (39.5–49.6) 47.6 (42.6–52.7) 32.5 (26.4–38.5)
Raised blood pressure 
(NOT on medication)
Men 38.3 (32.8–43.9) 44.1 (36.4–51.9) 35.6 (28.0–43.3)
Women 37.5 (32.4–42.5) 39.0 (33.2–44.8) 25.3 (19.8–30.8)
Raised blood glucose  
(or on medication)
Men 5.6 (3.1–8.0) 7.4 (3.9–10.9) 9.5 (6.3–12.7)
Women 12.5 (9.0–16.0) 11.2 (7.4–15.0) 3.9 (1.7–6.1)
Raised cholesterol 
(or on medication)
Men 15.2 (11.4–19.1) 21.1 (15.1–27.0) 18.4 (13.7–23.1)
Women 27.3 (22.1–32.5) 32.6 (26.3–39.0) 32.5 (26.3–38.7)
Republic of 
Moldova
Overweight  
(BMI ≥ 25)
Men 49.4 (44.1–54.6) 58.4 (53.4–63.4) 66.1 (59.7–72.6)
Women 55.3 (51.0–59.7) 65.3 (61.4–69.3) 43.5 (38.2–48.8)
Obesity  
(BMI ≥ 30)
Men 13.6 (10.7–16.5) 21.6 (18.0–25.2) 20.1 (15.0–25.2)
Women 29.1 (25.6–32.6) 36.4 (32.5–40.3) 16.2 (13.0–19.3)
Raised blood pressure 
(or on medication)
Men 37.9 (32.6–43.2) 45.5 (40.7–50.2) 36.2 (29.9–42.5)
Women 41.3 (37.2–45.5) 47.9 (43.8–52.0) 23.6 (19.4–27.8)
Raised blood pressure 
(NOT on medication)
Men 34.6 (29.2–39.9) 39.9 (35.0–44.9) 31.6 (25.3–38.0)
Women 32.3 (28.2–36.4) 37.6 (33.0–42.2) 16.5 (12.5–20.6)
Raised blood glucose  
(or on medication)
Men 12.0 (8.8–15.2) 12.1 (8.9–15.3) 9.2 (5.7–12.7)
Women 12.8 (10.6–15.1) 13.5 (11.0–15.9) 12.7 (9.2–16.3)
Raised cholesterol 
(or on medication)
Men 27.5 (22.7–32.4) 29.1 (24.5–33.7) 20.2 (14.3–26.1)
Women 31.0 (26.9–35.1) 33.6 (29.5–37.7) 31.3 (26.1–36.5)
Turkey
Overweight  
(BMI ≥ 25)
Men 71.9 (67.6–76.2) 59.9 (56.0–63.8) 59.1 (53.2–65.1)
Women 86.2 (84.3–88.1) 51.1 (47.0–55.2) 49.6 (42.3–57.0)
Obesity  
(BMI ≥ 30)
Men 31.4 (27.8–35.0) 17.5 (14.7–20.4) 20.9 (16.1–25.8)
Women 57.6 (54.9–60.3) 20.5 (17.6–23.5) 16.6 (9.9–23.2)
Raised blood pressure 
(or on medication)
Men 39.8 (35.9–43.7) 21.4 (18.0–24.7) 21.5 (16.4–26.7)
Women 45.3 (42.7–48.0) 18.2 (14.8–21.6) 14.3 (7.9–20.7)
Raised blood pressure 
(NOT on medication)
Men 28.8 (24.9–32.7) 16.0 (12.8–19.3) 13.6 (9.4–17.8)
Women 27.7 (25.0–30.3) 12.0 (8.9–15.1) 7.8 (4.0–11.5)
Raised blood glucose  
(or on medication)
Men 18.9 (14.6–23.2) 9.2 (5.7–12.7) 3.9 (0.9–6.8)
Women 19.9 (16.1–23.6) 4.6 (2.0–7.3) 7.3 (0.7–13.8)
Raised cholesterol 
(or on medication)
Men 21.6 (16.9–26.3) 20.8 (16.1–25.5) 20.1 (12.8–27.4)
Women 38.7 (34.5–42.8) 21.2 (15.6–26.8) 20.1 (11.9–28.3)
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Country Risk factor
Low
% (CI 95%)
Medium 
% (CI 95%)
High 
% (CI 95%)
Ukraine
Overweight  
(BMI ≥ 25)
Men 52.7 (34.9–70.5) 61.7 (56.5–66.9) 52.6 (34.8–70.4)
Women 67.8 (53.4–82.2) 64.1 (60.0–68.2) 52 (46.5–57.5)
Obesity  
(BMI ≥ 30)
Men 18.5 (8.0–28.9) 24.4 (18.1–30.6) 13.8 (7.6–19.9)
Women 37.1 (23.1–51.1) 32.7 (28.2–37.3) 23.2 (18.3–28.2)
Raised blood pressure 
(or on medication)
Men 42.9 (25.7–60.1) 39.6 (33.5–45.7) 24.3 (14.6–34.1)
Women 49.8 (35.0–64.6) 38.8 (34.4–43.2) 26.3 (21.8–30.9)
Raised blood pressure 
(NOT on medication)
Men 24.6 (12.6–36.7) 30.0 (22.8–37.2) 14.5 (7.5–21.6)
Women 15.7 (6.6–24.9) 21.1 (16.1–26.2) 14.6 (10.6–18.7)
Raised blood glucose  
(or on medication)
Men 7.2 (1.6–12.9) 6.6 (4.2–9.0) 6.6 (2.8–10.5)
Women 16.5 (6.9–26.1) 6.9 (5.1–8.6) 7.0 (4.1–9.8)
Raised cholesterol 
(or on medication)
Men 55.5 (37.0–73.9) 42.0 (34.6–49.5) 35.0 (26.9–43.0)
Women 53.8 (35.9–71.6) 44.1 (38.6–49.6) 33.7 (28.0–39.3)
Uzbekistan
Overweight  
(BMI ≥ 25)
Men 59.8 (43.3–76.2) 54.3 (48.6–59.9) 60.0 (51.5–68.6)
Women 58.6 (51.1–66.1) 55.5 (51.3–59.7) 70.2 (63.6–76.9)
Obesity  
(BMI ≥ 30)
Men 21.1 (5.9–36.3) 21.3 (17.4–25.2) 23.2 (16.0–30.4)
Women 26.4 (20.0–32.8) 24.9 (22.1–27.8) 29.9 (21.7–38.1)
Raised blood pressure 
(or on medication)
Men 38.5 (21.8–55.2) 37.1 (31.8–42.4) 45.7 (33.7–57.7)
Women 30.2 (21.3–39.1) 38.7 (34.7–42.8) 36.0 (23.6–48.5)
Raised blood pressure 
(NOT on medication)
Men 25.9 (14.7–37.1) 27.2 (22.6–31.7) 31.4 (15.5–47.4)
Women 16.7 (9.7–23.7) 19.1 (15.3–22.9) 19.2 (5.4–32.9)
Raised blood glucose  
(or on medication)
Men 6.5 (1.4–11.7) 8.2 (6.2–10.2) 12.0 (5.9–18.2)
Women 8.1 (4.0–12.2) 8.1 (6.5–9.6) 9.6 (5.6–13.6)
Raised cholesterol 
(or on medication)
Men 11.3 (4.7–17.9) 9.2 (6.7–11.7) 15.5 (9.0–22.1)
Women 9.6 (5.2–14.0) 14.1 (11.7–16.5) 20.5 (15.4–25.7)
 CI: confidence interval.
Table A1.12. Prevalence of behavioural risk factors by income level 
Country Risk factor
Low income
% (CI 95%)
High income 
% (CI 95%)
Armenia
Current tobacco use
Men 55.3 (50.2–60.4) 48.0 (41.8–54.3)
Women 1.4 (0.6–2.2) 2.3 (1.3–3.4)
Alcohol
Men 48.1 (41.2–55.1) 44.2 (36.7–51.8)
Women 21.4 (17.5–25.2) 21.7 (17.7–25.6)
Alcohol  
(heavy episodic)
Men 11.3 (7.3–15.3) 10.9 (7.0–14.7)
Women 0.1 (0.0–0.2) 0.2 (0.0–0.6)
Unhealthy diet  
(< 5 fruit/veg)
Men 82.3 (77.7–86.9) 74.9 (68.9–80.9)
Women 76.9 (73.2–80.5) 69.0 (64.1–73.9)
Unhealthy diet  
(add salt)
Men 40.1 (34.0–46.1) 40.4 (35.1–45.8)
Women 29.1 (25.1–33.0) 31.5 (27.0–36.0)
Unhealthy diet 
(processed foods)
Men 30.4 (24.5–36.4) 38.0 (31.6–44.3)
Women 27.4 (23.6–31.2) 28.3 (24.0–32.5)
Insufficient physical 
activity
Men 21.2 (16.2–26.1) 22.8 (17.0–28.5)
Women 18.0 (14.7–21.2) 23.7 (18.9–28.5)
Kyrgyzstan
Current tobacco use
Men 43.6 (36.3–50.9) 52.8 (44.7–60.8)
Women 1.9 (0.8–3.1) 2.9 (1.4–4.3)
Alcohol
Men 44.2 (34.7–53.7) 46.2 (37.7–54.7)
Women 15.7 (11.6–19.9) 20.4 (14.9–25.9)
Alcohol  
(heavy episodic)
Men 21.6 (15.2–27.9) 23.5 (18.0–29.1)
Women 2.4 (1.1–3.7) 2.6 (1.0–4.1)
Unhealthy diet  
(< 5 fruit/veg)
Men 76.6 (68.7–84.6) 78.2 (72.4–84.1)
Women 74.0 (68.0–80.0) 72.4 (65.1–79.7)
Unhealthy diet  
(add salt)
Men 21.2 (13.2–29.2) 20.4 (14.0–26.8)
Women 16.4 (11.2–21.7) 13.4 (9.3–17.6)
Unhealthy diet 
(processed foods)
Men 25.9 (18.8–33.0) 32.7 (25.7–39.7)
Women 26.6 (21.6–31.7) 25.8 (21.0–30.6)
Insufficient physical 
activity
Men 5.1 (2.8–7.5) 10.9 (7.2–14.5)
Women 13.3 (9.5–17.1) 14.2 (11.3–17.1)
63
GENDER AND NONCOMMUNICABLE DISEASES IN EUROPE ANNEX
Table A1.12 contd
Country Risk factor
Low income
% (CI 95%)
High income 
% (CI 95%)
Republic of 
Moldova
Current tobacco use
Men 43.4 (38.8–48.0) 43.9 (40.0–47.8)
Women 4.6 (3.2–5.9) 6.8 (5.0–8.5)
Alcohol
Men 71.5 (67.0–76.1) 68.0 (63.4–72.7)
Women 55.1 (51.2–59.1) 51.7 (47.7–55.7)
Alcohol  
(heavy episodic)
Men 31.8 (26.8–36.9) 26.0 (20.9–31.2)
Women 11.0 (8.6–13.4) 7.3 (5.5–9.2)
Unhealthy diet  
(< 5 fruit/veg)
Men 67.3 (62.1–72.5) 64.4 (60.0–68.7)
Women 71.3 (67.4–75.1) 63.5 (59.6–67.5)
Unhealthy diet  
(add salt)
Men 32.2 (27.3–37.2) 23.7 (19.7–27.6)
Women 23.7 (20.5–26.9) 16.6 (14.0–19.2)
Unhealthy diet 
(processed foods)
Men 35.5 (30.9–40.2) 37.4 (32.9–42.0)
Women 26.8 (23.3–30.3) 29.4 (25.9–32.9)
Insufficient physical 
activity
Men 9.1 (5.8–12.4) 12.3 (9.3–15.3)
Women 8.7 (6.7–10.7) 10.2 (7.8–12.6)
Turkey
Current tobacco use
Men 43.7 (40.0–47.4) 44.7 (39.6–49.7)
Women 16.8 (14.5–19.0) 28.6 (22.4–34.7)
Alcohol
Men 11.7 (9.0–14.4) 14.9 (11.1–18.8)
Women 2.1 (1.0–3.1) 5.0 (2.3–7.7)
Alcohol  
(heavy episodic)
Men 7.6 (5.5–9.8) 9.8 (6.3–13.3)
Women 1.1 (0.3–1.9) 3.8 (1.4–6.2)
Unhealthy diet  
(< 5 fruit/veg)
Men 87.7 (85.0–90.4) 86.8 (83.0–90.5)
Women 86.2 (83.7–88.7) 87.4 (83.7–91.2)
Unhealthy diet  
(add salt)
Men 30.2 (26.6–33.8) 25.1 (20.6–29.6)
Women 29.5 (26.5–32.5) 23.9 (18.2–29.5)
Unhealthy diet 
(processed foods)
Men 26.3 (22.6–30.0) 33.5 (28.9–38.1)
Women 24.6 (21.5–27.8) 28.5 (22.8–34.1)
Insufficient physical 
activity
Men 26.8 (23.4–30.3) 38.3 (32.6–44.0)
Women 47.1 (43.9–50.3) 53.6 (47.4–59.9)
Ukraine
Current tobacco use
Men 53.1 (39.2–67.0) 53.4 (45.0–61.9)
Women 16.6 (13.2–20.0) 21.5 (16.4–26.6)
Alcohol
Men 69.6 (60.6–78.6) 68.4 (61.5–75.2)
Women 48.5 (43.8–53.2) 49.9 (43.6–56.3)
Alcohol  
(heavy episodic)
Men 40.8 (25.4–56.2) 24.1 (13.9–34.3) 
Women 12.2 (8.6–15.7) 10.0 (5.7–14.3)
Unhealthy diet  
(< 5 fruit/veg)
Men 74.9 (66.3–83.5) 70.5 (62.5–78.5)
Women 58.5 (53.1–63.9) 55.1 (46.6–63.6)
Unhealthy diet  
(add salt)
Men 55.4 (43.3–67.6) 56.3 (47.9–64.6)
Women 37.0 (31.8–42.2) 39.6 (31.8–47.4)
Unhealthy diet 
(processed foods)
Men 32.3 (22.6–42.0) 34.0 (26.3–41.7)
Women 20.6 (16.3–24.8) 26.5 (20.2–32.7)
Insufficient physical 
activity
Men 7.4 (4.2–10.5) 8.4 (3.8–13.0)
Women 11.9 (8.2–15.5) 10.1 (6.1–14.0)
 CI: confidence interval.
Table A1.13. Prevalence of behavioural risk factors by employment status
Country Risk factor
Employed
% (CI 95%)
Unemployed or not in the 
labour force % (CI 95%)
Belarus
Current tobacco use
Men 50.2 (47.0–53.4) 43.3 (38.2–48.4)
Women 13.7 (11.9–15.5) 10.3 (7.7–12.9)
Alcohol
Men 68.8 (65.2–72.4) 54.0 (48.5–59.5)
Women 46.3 (42.8–49.7) 33.0 (28.6–37.3)
Alcohol  
(heavy episodic)
Men 37.0 (33.4–40.6) 29.1 (23.9–34.3)
Women 7.6 (6.0–9.3) 5.5 (3.9–7.1)
Unhealthy diet  
(< 5 fruit/veg)
Men 78.0 (74.2–81.8) 77.7 (72.3–83.0)
Women 68.0 (63.8–72.1) 69.1 (64.8–73.3)
Unhealthy diet  
(add salt)
Men 35.8 (31.6–39.9) 36.1 (30.5–41.6)
Women 27.5 (24.0–31.1) 28.8 (24.1–33.6)
Unhealthy diet 
(processed foods)
Men 45.4 (41.9–48.9) 38.2 (33.2–43.3)
Women 31.2 (28.0–34.3) 23.2 (19.6–26.7)
Insufficient physical 
activity
Men 9.8 (7.9–11.7) 21.2 (16.5–26.0)
Women 11.4 (9.4–13.4) 17.6 (14.3–20.8)
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Table A1.14. Prevalence of biological risk factors by income level
Country Risk factor
Low
% (CI 95%)
High 
% (CI 95%)
Armenia
Overweight  
(BMI ≥ 25)
Men 42.5 (35.7–49.4) 48.0 (40.4–55.6)
Women 51.5 (46.8–56.1) 48.3 (43.9–52.6)
Obesity  
(BMI ≥ 30)
Men 13.2 (9.1–17.2) 14.7 (10.2–19.2)
Women 26.3 (22.7–30.0) 23.2 (19.3–27.1)
Raised blood pressure 
(or on medication)
Men 42.1 (35.3–48.8) 36.7 (29.9–43.5)
Women 38.2 (34.1–42.4) 33.6 (28.9–38.3)
Raised blood pressure 
(NOT on medication)
Men 36.2 (29.2–43.2) 31.7 (24.7–38.7)
Women 28.5 (24.4–32.6) 25.4 (21.1–29.8)
Raised blood glucose  
(or on medication)
Men 3.7 (1.5–5.8) 8.9 (4.6–13.2)
Women 5.3 (3.7–6.8) 3.7 (2.0–5.5)
Raised cholesterol 
(or on medication)
Men 21.9 (16.0–27.9) 23.2 (17.4–28.9)
Women 25.9 (22.1–29.6) 23.3 (19.4–27.2)
Table A1.13 contd
Country Risk factor
Employed
% (CI 95%)
Unemployed or not in the 
labour force % (CI 95%)
Georgia
Current tobacco use
Men 59.1 (54.2–63.9) 54.7 (50.4–59.1)
Women 10.8 (7.9–13.7) 5.7 (4.4–7.0)
Alcohol
Men 61.3 (56.5–66.0) 57.0 (52.0–62.0)
Women 23.9 (20.2–27.7) 19.6 (17.2–22.0)
Alcohol  
(heavy episodic)
Men 37.2 (32.3–42.1) 33.8 (28.6–39.0)
Women 2.8 (1.2–4.3) 2.6 (1.4–3.7)
Unhealthy diet  
(< 5 fruit/veg)
Men 64.2 (58.9–69.5) 63.8 (58.7–68.9)
Women 60.1 (55.6–64.7) 63.2 (60.0–66.4)
Unhealthy diet  
(add salt)
Men 33.3 (28.2–38.3) 33.7 (28.5–38.9)
Women 21.8 (18.4–25.3) 20.2 (17.8–22.6)
Unhealthy diet 
(processed foods)
Men 19.9 (15.8–24.0) 18.1 (13.0–23.2)
Women 11.9 (9.2–14.7) 9.4 (7.8–11.1)
Insufficient physical 
activity
Men 17.2 (13.4–21.0) 15.5 (12.0–19.0)
Women 14.4 (11.2–17.6) 19.7 (17.3–22.1)
Republic of 
Moldova
Current tobacco use
Men 45.6 (41.5–49.6) 46.0 (37.2–54.7)
Women 6.1 (4.6–7.6) 5.6 (2.4–8.9)
Alcohol
Men 71.9 (67.5–76.3) 77.3 (69.9–84.6)
Women 55.1 (50.9–59.3) 68.4 (60.8–76.0)
Alcohol  
(heavy episodic)
Men 28.2 (23.7–32.8) 41.2 (33.7–48.7)
Women 8.6 (6.4–10.8) 14.0 (8.0–20.1)
Unhealthy diet  
(< 5 fruit/veg)
Men 65.2 (60.9–69.5) 62.7 (53.5–71.9)
Women 64.6 (60.5–68.7) 63.9 (54.7–73.0)
Unhealthy diet  
(add salt)
Men 28.4 (24.5–32.3) 29.0 (21.4–36.6)
Women 18.3 (15.6–21.1) 29.9 (21.4–38.3)
Unhealthy diet 
(processed foods)
Men 37.3 (33.2–41.3) 35.4 (27.2–43.7)
Women 28.0 (24.3–31.7) 41.1 (32.9–49.4)
Insufficient physical 
activity
Men 11.3 (8.5–14.1) 8.4 (0.7–16.1)
Women 10.0 (7.0–12.9) 9.6 (5.0–14.2)
Ukraine
Current tobacco use
Men 51.6 (42.2–61.0) 47.7 (41.5–53.8)
Women 18.3 (15.0–21.7) 13.9 (10.5–17.2)
Alcohol
Men 69.5 (62.9–76.0) 58.7 (52.7–64.6)
Women 46.2 (41.7–50.7) 42.9 (38.1–47.6)
Alcohol  
(heavy episodic)
Men 31.6 (19.5–43.6) 25.7 (20.3–31.1)
Women 9.9 (6.9–12.9) 9.0 (6.4–11.5)
Unhealthy diet  
(< 5 fruit/veg)
Men 75.8 (69.4–82.2) 68.6 (61.9–75.2)
Women 59.7 (54.7–64.7) 58.9 (53.3–64.6)
Unhealthy diet  
(add salt)
Men 56.2 (47.5–64.9) 45.3 (38.9–51.6)
Women 35.8 (31.2–40.4) 37.0 (31.7–42.2)
Unhealthy diet 
(processed foods)
Men 31.7 (24.5–38.9) 33.8 (27.2–40.4)
Women 21.4 (17.8–25.0) 20.4 (16.5–24.2)
Insufficient physical 
activity
Men 7.6 (4.7–10.6) 12.9 (9.2–16.6)
Women 8.4 (5.3–11.5) 13.9 (10.5–17.3)
 CI: confidence interval.
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Table A1.14 contd
Country Risk factor
Low
% (CI 95%)
High 
% (CI 95%)
Kyrgyzstan
Overweight  
(BMI ≥ 25)
Men 47.0 (39.7–54.4) 50.4 (40.5–60.3)
Women 63.0 (57.7–68.2) 65.1 (59.8–70.5)
Obesity  
(BMI ≥ 30)
Men 16.0 (11.4–20.5) 19.2 (14.2–24.2)
Women 28.1 (23.7–32.5) 30.8 (26.9–34.7)
Raised blood pressure 
(or on medication)
Men 40.7 (34.7–46.7) 44.8 (37.3–52.3)
Women 47.3 (43.1–51.6) 39.1 (34.6–43.6)
Raised blood pressure 
(NOT on medication)
Men 37.0 (31.0–42.9) 41.5 (34.1–48.9)
Women 38.4 (34.3–42.6) 32.5 (27.9–37.0)
Raised blood glucose  
(or on medication)
Men 6.3 (3.4–9.1) 3.4 (1.5–5.3)
Women 6.3 (3.7–8.9) 4.8 (2.6–6.9)
Raised cholesterol 
(or on medication)
Men 16.4 (12.2–20.6) 17.7 (13.8–21.6)
Women 25.2 (21.1–29.3) 33.5 (26.6–40.4)
Republic of 
Moldova
Overweight  
(BMI ≥ 25)
Men 49.7 (45.0–54.4) 62.1 (57.3–66.9)
Women 55.6 (51.3–59.9) 56.1 (52.5–59.8)
Obesity  
(BMI ≥ 30)
Men 16.2 (13.3–19.0) 19.3 (16.1–22.5)
Women 30.4 (27.0–33.9) 26.5 (23.6–29.5)
Raised blood pressure 
(or on medication)
Men 44.3 (39.3–49.2) 36.9 (32.9–40.9)
Women 45.2 (40.8–49.6) 33.5 (30.2–36.9)
Raised blood pressure 
(NOT on medication)
Men 40.7 (35.6–45.8) 31.6 (27.4–35.8)
Women 35.7 (31.3–40.1) 24.7 (21.3–28.0)
Raised blood glucose  
(or on medication)
Men 12.8 (9.9–15.8) 10.2 (7.6–12.7)
Women 13.7 (11.4–16.0) 12.2 (10.0–14.4)
Raised cholesterol 
(or on medication)
Men 29.3 (24.7–33.8) 24.2 (20.1–28.4)
Women 32.1 (28.2–36.0) 31.9 (28.6–35.1)
Turkey
Overweight  
(BMI ≥ 25)
Men 65.4 (61.8–69.1) 63.7 (58.5–68.9)
Women 70.6 (67.6–73.6) 57.7 (51.6–63.9)
Obesity  
(BMI ≥ 30)
Men 22.8 (19.8–25.9) 21.2 (16.6–25.7)
Women 40.6 (37.7–43.5) 27.3 (21.8–32.7)
Raised blood pressure 
(or on medication)
Men 26.9 (23.7–30.2) 26.6 (21.3–31.9)
Women 31.8 (29.0–34.6) 26.2 (20.3–32.2)
Raised blood pressure 
(NOT on medication)
Men 19.0 (15.9–22.1) 20.3 (15.0–25.6)
Women 18.0 (15.5–20.4) 16.2 (11.1–21.4)
Raised blood glucose  
(or on medication)
Men 11.3 (7.8–14.8) 8.9 (4.7–13.1)
Women 13.5 (9.8–17.1) 8.3 (3.6–13.0)
Raised cholesterol 
(or on medication)
Men 20.7 (15.9–25.5) 20.8 (14.6–27.0)
Women 31.7 (26.7–36.6) 23.3 (16.6–30.1)
Ukraine
Overweight  
(BMI ≥ 25)
Men 52.8 (38.6–66.9) 66.3 (58.1–74.6)
Women 67.0 (62.8–71.1) 51.9 (44.9–58.9)
Obesity  
(BMI ≥ 30)
Men 18.1 (11.8–24.4) 24.7 (14.4–35.0)
Women 37.2 (32.2–42.2) 18.1 (12.8–23.3)
Raised blood pressure 
(or on medication)
Men 33.1 (23.4–42.8) 35.0 (24.9–45.1)
Women 41.3 (36.6–45.9) 22.9 (17.2–28.7)
Raised blood pressure 
(NOT on medication)
Men 22.3 (14.0–30.6) 25.4 (13.6–37.3)
Women 23.6 (18.2–29.1) 11.8 (6.7–16.9)
Raised blood glucose  
(or on medication)
Men 7.7 (4.7–10.7) 7.7 (3.1–12.2)
Women 9.5 (7.0–11.9) 5.2 (2.5–7.9)
Raised cholesterol 
(or on medication)
Men 40.6 (33.0–48.3) 41.5 (10.4–52.6)
Women 43.7 (37.8–49.6) 32.9 (25.5–40.2)
 CI: confidence interval.
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Table A1.15. Prevalence of biological risk factors by employment status
Country Risk factor
Employed
% (CI 95%)
Unemployed or not in the 
labour force % (CI 95%)
Belarus
Overweight  
(BMI ≥ 25)
Men 62.7 (59.6–65.9) 57.8 (52.6–63.0)
Women 56.5 (53.5–59.4) 66.5 (62.2–70.9)
Obesity  
(BMI ≥ 30)
Men 20.0 (17.5–22.5) 20.6 (16.8–24.4)
Women 26.8 (24.1–29.4) 37.0 (33.1–41.0)
Raised blood pressure 
(or on medication)
Men 41.6 (38.5–44.7) 57.0 (51.5–62.4)
Women 35.6 (33.0–38.2) 61.1 (56.7–65.4)
Raised blood pressure 
(NOT on medication)
Men 33.1 (29.8–36.4) 42.3 (35.9–48.8)
Women 21.4 (18.8–23.9) 35.6 (30.7–40.4)
Raised blood glucose  
(or on medication)
Men 2.5 (1.5–3.6) 5.0 (3.1–6.9)
Women 2.5 (1.7–3.3) 6.8 (4.8–8.8)
Raised cholesterol 
(or on medication)
Men 34.1 (31.0–37.2) 31.4 (26.9–36.0)
Women 38.3 (35.3–41.2) 51.0 (46.8–55.3)
Georgia
Overweight  
(BMI ≥ 25)
Men 68.5 (62.8–74.2) 62.5 (57.5–67.6)
Women 64.7 (60.3–69.1) 63.5 (60.7–66.3)
Obesity  
(BMI ≥ 30)
Men 32.6 (28.1–37.1) 28.1 (23.6–32.5)
Women 31.5 (27.5–35.6) 37.5 (34.8–40.1)
Raised blood pressure 
(or on medication)
Men 35.3 (30.5–40.0) 41.8 (37.0–46.6)
Women 32.0 (28.1–36.0) 38.6 (36.0–41.1)
Raised blood pressure 
(NOT on medication)
Men 26.0 (21.2–30.7) 31.4 (26.5–36.3)
Women 19.3 (15.7–23.0) 22.4 (19.8–25.0)
Raised blood glucose  
(or on medication)
Men 5.0 (2.9–7.2) 4.5 (2.8–6.1)
Women 3.2 (1.5–4.8) 4.6 (3.6–5.6)
Raised cholesterol 
(or on medication)
Men 24.1 (18.7–29.5) 19.8 (15.9–23.8)
Women 36.1 (31.4–40.9) 32.0 (29.1–34.8)
Republic of 
Moldova
Overweight  
(BMI ≥ 25)
Men 60.7 (56.6–64.7) 53.5 (44.8–62.2)
Women 58.4 (54.7–62.1) 61.5 (52.7–70.3)
Obesity  
(BMI ≥ 30)
Men 18.7 (15.9–21.6) 16.6 (11.1–22.0)
Women 26.8 (23.9–29.8) 39.4 (31.3–47.4)
Raised blood pressure 
(or on medication)
Men 37.9 (33.5–42.2) 46.3 (37.4–55.1)
Women 36.1 (32.6–39.6) 57.2 (47.7–66.7)
Raised blood pressure 
(NOT on medication)
Men 33.6 (29.2–38.1) 43.8 (34.6–52.9)
Women 28.7 (25.2–32.3) 51.6 (41.0–62.3)
Raised blood glucose  
(or on medication)
Men 10.8 (8.2–13.4) 13.1 (7.4–18.8)
Women 13.5 (10.8–16.1) 13.9 (7.7–20.1)
Raised cholesterol 
(or on medication)
Men 24.5 (20.7–28.2) 30.2 (21.8–38.6)
Women 32.8 (29.3–36.3) 37.2 (27.8–46.5)
Ukraine
Overweight  
(BMI ≥ 25)
Men 60.7 (56.6–64.7) 53.5 (44.8–62.2)
Women 58.4 (54.7–62.1) 61.5 (52.7–70.3)
Obesity  
(BMI ≥ 30)
Men 57.7 (47.1–68.3) 58.1 (51.7–64.4)
Women 57.8 (53.4–62.3) 63.8 (59.2–68.4)
Raised blood pressure 
(or on medication)
Men 20.0 (13.8–26.3) 21.1 (15.9–26.3)
Women 28.1 (23.3–32.8) 32.3 (27.9–36.6)
Raised blood pressure 
(NOT on medication)
Men 29.7 (22.2–37.1) 46.2 (39.6–52.8)
Women 25.8 (21.8–29.9) 48.9 (43.7–54.2)
Raised blood glucose  
(or on medication)
Men 21.5 (14.3–28.7) 32.0 (24.4–39.7)
Women 13.9 (10.0–17.7) 26.9 (20.6–33.2)
Raised cholesterol 
(or on medication)
Men 6.6 (4.0–9.3) 6.1 (3.8–8.5)
Women 4.9 (3.1–6.7) 11.3 (8.4–14.2)
CI: confidence interval.
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Table A1.16. Percentage with three or more risk factors by age group in Georgia
Age – STEPS Year
Men
% (CI 95%)
Women 
% (CI 95%)
18–29
2010 31.2 (25.9–36.5) 6.3 (4.2–8.4)
2016 29.2 (21.7–36.8) 7.9 (4.5–11.3)
30–44
2010 49.7 (44.0–55.3) 19.5 (16.4–22.5)
2016 44.9 (37.8–52.0) 15.9 (12.7–19.1)
45–59
2010 57.4 (52.3–62.4) 39.9 (36.9–43.0)
2016 57.2 (50.8–63.5) 38.9 (35.2–42.7)
60+
2010 58.7 (51.6–65.9) 54.3 (49.3–59.3)
2016 50.8 (43.5–58.0) 51.2 (46.4–56.1)
Age – migrant health survey Men Women
18–29 23.8 (10.4–37.1) 6.6 (4.3–8.9)
30–44 55.9 (42.8–69.0) 29.4 (23.9–34.8)
45–59 74.4 (62.7–86.1) 52.6 (46.4–58.9)
60+ 57.4 (42.3–72.5) 62.1 (46.7–77.5)
CI: confidence interval.
Table A1.17. Prevalence of biological risk factors with differences by marital status
Country Risk factor
Currently living  
without a partner
% (CI 95%)
Currently living  
with a partner
% (CI 95%)
Belarus
Overweight  
(BMI ≥ 25)
Men 50.6 (45.6–55.5) 67.9 (64.9–71.0)
Women 52.7 (49.2–56.2) 64.6 (61.6–67.6)
Obesity  
(BMI ≥ 30)
Men 12.5 (9.9–15.1) 24.7 (21.8–27.5)
Women 24.4 (21.4–27.3) 34.1 (31.3–36.9)
Raised blood pressure 
(or on medication)
Men 32.4 (27.9–36.9) 53.4 (50.2–56.7)
Women 41.9 (38.5–45.2) 45.7 (42.7–48.8)
Raised blood pressure 
(NOT on medication)
Men 27.0 (22.7–31.4) 41.0 (37.2–44.8)
Women 22.5 (19.5–25.4) 27.1 (23.9–30.2)
Raised blood glucose  
(or on medication)
Men 2.0 (1.0–3.0) 3.9 (2.6–5.2)
Women 3.6 (2.4–4.9) 4.1 (2.9–5.4)
Raised cholesterol 
(or on medication)
Men 22.0 (18.5–25.6) 39.9 (36.6–43.2)
Women 41.0 (37.2–44.8) 43.6 (40.6–46.7)
Uzbekistan
Overweight  
(BMI ≥ 25)
Men 37.7 (28–47.4) 63.8 (59.2–68.3)
Women 40.4 (33.1–47.6) 63.3 (59.5–67.1)
Obesity  
(BMI ≥ 30)
Men 11.3 (6.4–16.2) 26.1 (21.5–30.6)
Women 15.3 (11.1–19.5) 29.2 (26–32.3)
Raised blood pressure 
(or on medication)
Men 23.8 (14.4–33.3) 45.9 (40–51.8)
Women 28.7 (21–36.4) 40.4 (36.3–44.5)
Raised blood pressure 
(NOT on medication)
Men 20.8 (11.6–30) 31.7 (26.9–36.5)
Women 18.2 (10.2–26.1) 19.0 (15.7–22.3)
Raised blood glucose  
(or on medication)
Men 6.0 (2.2–9.8) 9.9 (8–11.9)
Women 7.4 (4.6–10.2) 8.3 (6.6–10)
Raised cholesterol 
(or on medication)
Men 6.4 (2.5–10.2) 12.3 (9.4–15.1)
Women 12.9 (8.3–17.5) 14.5 (12.5–16.4)
 CI: confidence interval.
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Table A1.18. Prevalence of biological risk factors with differences by ethnicity in Kyrgyzstan
Risk factor
Kyrgyz
% (CI 95%)
Russian 
% (CI 95%)
Uzbek 
% (CI 95%)
Overweight (BMI ≥ 25) Men 50.7 (44.0–57.4) 36.4 (10.4–62.4) 45.5 (33.5–57.5)
Women 64.5 (60.7–68.3) 64.6 (54.0–75.2) 55.5 (46.7–64.4)
Obesity (BMI ≥ 30) Men 17.7 (14.1–21.2) 10.4 (0.5–20.3) 23.5 (13.9–33.0)
Women 28.7 (25.4–32.1) 34.2 (26.0–42.4) 29.1 (22.2–35.9)
Raised blood pressure (or on medication) Men 42.9 (37.9–48.0) 35.4 (22.2–48.5) 41.3 (28.6–53.9)
Women 41.8 (38.3–45.3) 49.8 (39.1–60.4) 45.7 (37.2–54.3)
Raised blood pressure (NOT on medication) Men 39.3 (34.2–44.5) 32.6 (20.1–45.1) 35.1 (22.2–48.0)
Women 34.6 (31.1–38.1) 39.8 (28.9–50.7) 36.6 (27.2–45.9)
Raised blood glucose (or on medication) Men 6.9 (4.8–8.9) 5.2 (0.0–11.1) 7.9 (1.9–14.0)
Women 9.2 (6.9–11.5) 7.3 (3.2–11.3) 19.0 (6.7–31.3)
Raised cholesterol (or on medication) Men 15.9 (12.6–19.2) 25.6 (17.5–33.8) 20.1 (9.3–30.9)
Women 28.5 (25.1–31.9) 55.3 (44.8–65.7) 19.1 (12.4–25.8)
 CI: confidence interval.
Table A1.19. Percentages not measured for risk factors by a health-care professional
Country Risk factor measurement
Men
% (CI 95%)
Women
% (CI 95%)
Armenia
Blood pressure not measured 39.4 (34.0–44.8) 23.2 (20.4–25.9)
Blood glucose not measured 71.6 (68.1–75.1) 56.0 (52.7–59.3)
Cholesterol not measured 75.5 (71.5–79.5) 66.4 (63.1–69.7)
Belarus
Blood pressure not measured 2.1 (1.4–2.9) 1.0 (0.4–1.5)
Blood glucose not measured 12.9 (10.2–15.6) 9.7 (7.6–11.8)
Cholesterol not measured 23.4 (20.1–26.7) 19.1 (16.4–21.9)
Georgia
Blood pressure not measured 30.1 (26.9–33.3) 15.4 (13.6–17.3)
Blood glucose not measured 68.7 (65.6–71.7) 56.7 (54.2–59.1)
Cholesterol not measured 86.2 (84.0–88.3) 82.5 (80.6–84.3)
Kyrgyzstan
Blood pressure not measured 40.4 (32.8–47.9) 18.1 (14.0–22.3)
Blood glucose not measured 79.9 (76.2–83.6) 67.0 (62.5–71.6)
Cholesterol not measured 87.3 (83.2–91.4) 83.9 (81.3–86.5)
Republic of 
Moldova
Blood pressure not measured 10.8 (8.6–13.0) 6.0 (4.6–7.3)
Blood glucose not measured 45.4 (41.7–49.1) 34.9 (32.0–37.8)
Cholesterol not measured 64.0 (60.3–67.7) 56.5 (53.6–59.4)
Turkey
Blood pressure not measured 16.1 (14.1–18.2) 11.1 (9.5–12.7)
Blood glucose not measured 39.9 (37.2–42.6) 30.2 (27.9–32.6)
Cholesterol not measured 50.4 (47.6–53.2) 40.9 (38.4–43.3)
Ukraine
Blood pressure not measured 9.7 (7.0–12.4) 7.0 (5.2–8.8)
Blood glucose not measured 29.6 (24.1–35.0) 25.1 (21.9–28.3)
Cholesterol not measured 67.7 (62.1–73.2) 60.1 (56.6–63.6)
Uzbekistan
Blood pressure not measured 50.8 (44.8–56.7) 41.8 (37.7–45.9)
Blood glucose not measured 79.3 (75.8–82.8) 71.3 (68.1–74.5)
Cholesterol not measured 91.1 (88.7–93.4) 89.9 (87.8–91.9)
CI: confidence interval.
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Table A1.20. Percentages not measured for risk factors by age group
Country Risk factor
Aged 18–29
% (CI 95%)
Aged 30–44
% (CI 95%)
Aged 45–59
% (CI 95%)
Aged 60–69
% (CI 95%)
Armenia
Blood pressure not 
measured
Men 45.2 (36.5–54.0) 39.5 (31.1–47.9) 36.2 (28.2–44.3) 27.5 (18.8–36.1)
Women 26.1 (20.1–32.1) 26.6 (22.6–30.5) 20.1 (16.1–24.1) 12.0 (7.9–16.1)
Blood glucose not 
measured
Men 78.1 (71.8–84.5) 77.6 (70.5–84.8) 61.5 (54.4–68.5) 57.8 (49.0–66.6)
Women 65.8 (59.0–72.7) 58.2 (53.0–63.4) 46.9 (41.9–52.0) 41.1 (34.8–47.3)
Cholesterol not 
measured
Men 81.5 (75.3–87.6) 82.4 (76.1–88.8) 65.9 (58.4–73.3) 59.5 (50.7–68.3)
Women 74.4 (68.0–80.7) 70.8 (66.0–75.7) 56.8 (51.6–61.9) 53.1 (46.6–59.5)
Belarus
Blood pressure not 
measured
Men 3.9 (1.7–6.1) 1.4 (0.5–2.3) 1.8 (0.8–2.8) 1.1 (0.1–2.2)
Women 2.5 (0.3–4.8) 0.6 (0.0–1.1) 0.5 (0.0–1.0) 0.6 (0.0–1.3)
Blood glucose not 
measured
Men 16.4 (11.3–21.5) 13.5 (9.6–17.5) 10.6 (7.5–13.8) 10.1 (6.4–13.7)
Women 15.7 (11.0–20.4) 9.7 (6.9–12.6) 7.9 (5.5–10.2) 5.8 (3.6–8.0)
Cholesterol not 
measured
Men 35.3 (28.2–42.5) 24.1 (19.4–28.9) 16.1 (12.4–19.7) 15.8 (11.4–20.2)
Women 36.4 (29.6–43.1) 20.0 (16.0–24.0) 13.3 (10.4–16.1) 7.3 (4.9–9.7)
Georgia
Blood pressure not 
measured
Men 54.7 (47.0–62.3) 29.3 (23.0–35.6) 18.4 (13.5–23.3) 10.0 (6.1–13.8)
Women 23.9 (18.5–29.2) 15.4 (12.4–18.4) 13.7 (11.2–16.3) 7.1 (5.0–9.2)
Blood glucose not 
measured
Men 81.3 (75.2–87.3) 74.5 (69.1–80.0) 58.7 (53.6–63.8) 52.7 (45.7–59.6)
Women 66.0 (60.7–71.4) 60.8 (56.5–65.2) 53.8 (49.9–57.6) 41.9 (37.8–45.9)
Cholesterol not 
measured
Men 95.1 (92.4–97.8) 89.1 (85.3–92.9) 78.7 (74.5–83.0) 78.4 (72.0–84.8)
Women 88.7 (85.2–92.3) 88.2 (85.6–90.8) 78.2 (75.1–81.3) 71.6 (67.2–76.0)
Aged 25–34
% (CI 95%)
Aged 35–44
% (CI 95%)
Aged 45–54
% (CI 95%)
Aged 55–64
% (CI 95%)
Kyrgyzstan
Blood pressure not 
measured
Men 50.8 (39.7–61.8) 39.7 (30.7–48.7) 33.5 (22.7–44.3) 21.8 (14.6–29.1)
Women 21.9 (15.9–27.8) 20.0 (14.5–25.5) 15.9 (11.1–20.7) 9.9 (5.4–14.4)
Blood glucose not 
measured
Men 86.0 (77.7–94.2) 82.3 (76.5–88.1) 73.1 (66.6–79.5) 68.7 (60.5–77.0)
Women 71.8 (64.7–78.8) 71.8 (65.6–78.0) 66.7 (61.2–72.2) 49.9 (42.3–57.6)
Cholesterol not 
measured
Men 90.0 (81.3–98.6) 91.7 (88.0–95.5) 82.9 (76.9–88.9) 78.9 (72.2–85.7)
Women 90.2 (86.8–93.5) 85.1 (80.6–89.7) 80.5 (75.8–85.2) 72.0 (66.0–77.9)
Aged 18–29
% (CI 95%)
Aged 30–44
% (CI 95%)
Aged 45–59
% (CI 95%)
Aged 60–69
% (CI 95%)
Republic of 
Moldova
Blood pressure not 
measured
Men 14.1 (9.2–19.0) 10.5 (7.0–14.0) 7.8 (5.5–10.1) 7.4 (4.1–10.6)
Women 7.6 (5.0–10.2) 5.8 (3.8–7.7) 5.1 (3.5–6.7) 3.7 (2.0–5.5)
Blood glucose not 
measured
Men 58.8 (51.6–65.9) 40.3 (35.3–45.4) 38.0 (33.3–42.7) 30.3 (24.4–36.3)
Women 52.9 (47.2–58.6) 34.4 (30.0–38.8) 22.3 (18.8–25.9) 15.5 (12.2–18.8)
Cholesterol not 
measured
Men 73.3 (66.4–80.1) 62.0 (56.6–67.3) 57.1 (52.2–61.9) 53.7 (46.9–60.6)
Women 73.4 (68.9–77.9) 56.0 (51.2–60.7) 44.5 (40.5–48.5) 38.6 (34.0–43.3)
Aged 15–29
% (CI 95%)
Aged 30–44
% (CI 95%)
Aged 45–59
% (CI 95%)
Aged 60–69
% (CI 95%)
Turkey
Blood pressure not 
measured
Men 32.0 (27.2–36.9) 11.6 (8.7–14.5) 7.3 (5.2–9.5) 4.7 (2.3–7.0)
Women 23.4 (19.4–27.4) 6.9 (4.6–9.2) 5.8 (4.0–7.6) 3.8 (2.0–5.6)
Blood glucose not 
measured
Men 62.4 (57.8–66.9) 37.9 (33.1–42.7) 26.7 (22.2–31.2) 13.9 (9.5–18.2)
Women 52.1 (47.1–57.2) 25.8 (22.2–29.4) 17.8 (14.5–21.1) 13.7 (10.0–17.4)
Cholesterol not 
measured
Men 72.2 (67.7–76.6) 49.9 (45.0–54.9) 35.6 (30.7–40.5) 23.4 (17.9–29.0)
Women 64.3 (59.9–68.8) 37.4 (33.4–41.4) 25.8 (22.2–29.3) 22.0 (17.4–26.6)
Aged 18–29
% (CI 95%)
Aged 30–44
% (CI 95%)
Aged 45–59
% (CI 95%)
Aged 60–69
% (CI 95%)
Ukraine
Blood pressure not 
measured
Men 11.4 (5.9–16.9) 10.3 (5.4–15.3) 8.4 (5.3–11.6) 7.7 (2.3–13.1)
Women 14.5 (9.0–20.0) 7.3 (4.2–10.4) 3.4 (1.6–5.2) 3.1 (1.1–5.0)
Blood glucose not 
measured
Men 39.7 (30.4–49.1) 26.6 (17.3–36.0) 26.4 (20.0–32.8) 30.2 (23.4–37.1)
Women 33.7 (25.9–41.6) 28.2 (22.7–33.7) 20.2 (15.6–24.8) 16.8 (12.8–20.8)
Cholesterol not 
measured
Men 66.9 (57.6–76.3) 71.1 (61.0–81.2) 64.4 (56.5–72.2) 64.8 (58.3–71.4)
Women 68.4 (62.0–74.9) 63.6 (57.9–69.2) 54.2 (48.6–59.8) 53.2 (47.3–59.2)
Aged 18–29
% (CI 95%)
Aged 30–44
% (CI 95%)
Aged 45–59
% (CI 95%)
Uzbekistan
Blood pressure not 
measured
Men 57.8 (45.9–69.7) 53.8 (48.3–59.2) 37.3 (33.0–41.6)
Women 50.6 (43.2–58.0) 42.1 (36.8–47.3) 30.4 (27.0–33.8)
Blood glucose not 
measured
Men 87.9 (82.6–93.2) 77.9 (72.4–83.5) 68.1 (63.4–72.9)
Women 80.1 (74.3–85.9) 71.5 (67.1–75.8) 60.0 (55.6–64.4)
Cholesterol not 
measured
Men 95.9 (93.1–98.7) 87.8 (83.1–92.4) 87.5 (84.4–90.6)
Women 92.7 (88.9–96.4) 89.9 (87.2–92.6) 86.4 (84.0–88.8)
 CI: confidence interval.
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Table A1.21. Percentage not measured for risk factors by geographic location
Country Risk factor measurement
Rural
% (CI 95%)
Urban
% (CI 95%)
Belarus
Blood pressure not measured
Men 2.6 (1.4–3.9) 1.6 (0.8–2.5)
Women 0.8 (0.2–1.4) 1.1 (0.2–2.0)
Blood glucose not measured
Men 14.2 (10.0–18.5) 11.7 (8.2–15.3)
Women 13.1 (9.3–16.9) 7.1 (4.8–9.4)
Cholesterol not measured
Men 25.1 (20.3–29.8) 21.8 (17.3–26.4)
Women 22.6 (18.3–26.9) 16.5 (12.9–20.0)
Georgia
Blood pressure not measured
Men 33.9 (28.8–38.9) 26.1 (22.0–30.2)
Women 15.4 (12.7–18.2) 15.4 (13.0–17.9)
Blood glucose not measured
Men 69.9 (65.6–74.2) 67.4 (63.2–71.7)
Women 58.5 (54.9–62.1) 55.0 (51.6–58.4)
Cholesterol not measured
Men 87.3 (84.3–90.3) 85.0 (81.9–88.0)
Women 86.0 (83.5–88.6) 79.2 (76.8–81.6)
Kyrgyzstan
Blood pressure not measured
Men 45.5 (38.9–52.2) 29.1 (14.7–43.6)
Women 20.2 (14.7–25.7) 14.5 (8.7–20.4)
Blood glucose not measured
Men 83.8 (80.1–87.4) 71.5 (64.9–78.1)
Women 74.3 (70.0–78.6) 54.4 (46.4–62.4)
Cholesterol not measured
Men 90.7 (87.5–94.0) 80.0 (71.4–88.5)
Women 86.4 (83.4–89.4) 79.5 (74.6–84.4)
Republic of 
Moldova
Blood pressure not measured
Men 12.5 (9.0–15.9) 8.9 (6.2–11.5)
Women 6.3 (4.3–8.3) 5.6 (3.8–7.3)
Blood glucose not measured
Men 50.0 (44.7–55.4) 39.9 (35.0–44.9)
Women 35.5 (31.5–39.6) 34.3 (30.2–38.3)
Cholesterol not measured
Men 68.1 (62.9–73.3) 59.2 (54.0–64.4)
Women 56.6 (52.2–61.0) 56.4 (52.7–60.0)
Turkey
Blood pressure not measured
Men 15.8 (12.3–19.2) 16.2 (13.8–18.7)
Women 12.9 (9.6–16.2) 10.7 (8.8–12.5)
Blood glucose not measured
Men 43.0 (37.7–48.3) 39.0 (35.8–42.1)
Women 37.4 (32.3–42.5) 28.4 (25.7–31.1)
Cholesterol not measured
Men 57.2 (51.8–62.5) 48.4 (45.1–51.7)
Women 47.9 (42.6–53.1) 39.1 (36.3–42.0)
Ukraine
Blood pressure not measured
Men 13.0 (7.4–18.6) 8.1 (5.4–10.8)
Women 7.2 (4.3–10.2) 6.8 (4.5–9.1)
Blood glucose not measured
Men 30.7 (22.1–39.3) 29.0 (22.1–35.8)
Women 25.2 (20.1–30.2) 25.0 (20.9–29.2)
Cholesterol not measured
Men 64.8 (56.4–73.1) 69.0 (62.0–76.1)
Women 62.8 (56.9–68.6) 58.3 (54.0–62.6)
Uzbekistan
Blood pressure not measured
Men 52.8 (45.9–59.8) 45.4 (34.7–56.2)
Women 41.1 (36.0–46.3) 43.2 (35.0–51.5)
Blood glucose not measured
Men 77.9 (73.7–82.1) 82.8 (76.4–89.3)
Women 70.8 (66.8–74.9) 72.4 (66.0–78.7)
Cholesterol not measured
Men 92.0 (89.6–94.4) 88.7 (83.5–93.9)
Women 90.6 (87.9–93.3) 88.3 (84.7–92.0)
 CI: confidence interval.
Table A1.22. Percentage not measured for risk factors by education level
Country Risk factor measurement
Low
% (CI 95%)
Medium
% (CI 95%)
High
% (CI 95%)
Armenia
Blood pressure not measured
Men 44.2 (38.0–50.3) 38.5 (30.0–47.1) 30.2 (20.0–40.5)
Women 23.3 (19.2–27.5) 22.9 (18.2–27.6) 23.3 (18.0–28.6)
Blood glucose not measured
Men 75.7 (70.9–80.5) 69.7 (62.0–77.4) 65.0 (56.8–73.1)
Women 59.6 (54.4–64.7) 56.6 (51.1–62.1) 49.4 (43.5–55.3)
Cholesterol not measured
Men 81.2 (76.5–85.9) 69.7 (61.5–78.0) 69.1 (61.2–77.1)
Women 69.8 (65.2–74.5) 68.4 (63.7–73.1) 58.2 (52.0–64.4)
Belarus
Blood pressure not measured
Men 3.7 (1.8–5.6) 1.2 (0.5–1.9) 3.0 (0.9–5.1)
Women 1.4 (0.0–2.9) 0.8 (0.2–1.4) 0.9 (0.1–1.7)
Blood glucose not measured
Men 17.7 (12.6–22.8) 11.2 (8.5–13.9) 12.2 (7.8–16.5)
Women 12.7 (8.6–16.9) 9.8 (7.4–12.2) 7.7 (5.0–10.4)
Cholesterol not measured
Men 28.6 (22.9–34.3) 22.0 (18.4–25.6) 21.3 (16.1–26.5)
Women 22.0 (16.5–27.6) 19.0 (15.9–22.1) 17.5 (13.5–21.5)
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Country Risk factor measurement
Low
% (CI 95%)
Medium
% (CI 95%)
High
% (CI 95%)
Georgia
Blood pressure not measured
Men 33.4 (26.5–40.3) 32.8 (27.8–37.9) 21.6 (15.9–27.4)
Women 17.6 (14.3–20.9) 16.9 (14.1–19.8) 10.1 (7.3–12.9)
Blood glucose not measured
Men 72.3 (66.7–77.8) 72.1 (67.6–76.7) 58.7 (52.5–64.9)
Women 58.9 (54.2–63.6) 59.6 (56.3–62.8) 48.4 (43.8–53.0)
Cholesterol not measured
Men 89.9 (86.6–93.3) 87.1 (84.1–90.0) 80.8 (76.2–85.4)
Women 85.1 (82.0–88.2) 84.5 (82.1–87.0) 75.3 (71.6–79.0)
Kyrgyzstan
Blood pressure not measured
Men 45.7 (37.5–53.9) 35.7 (28.3–43.1) 35.1 (20.0–50.2)
Women 19.7 (13.9–25.6) 15.5 (10.8–20.3) 17.7 (11.6–23.9)
Blood glucose not measured
Men 86.9 (83.3–90.5) 78.6 (72.8–84.4) 68.5 (58.4–78.7)
Women 69.1 (62.3–75.9) 65.1 (58.5–71.7) 64.4 (56.2–72.6)
Cholesterol not measured
Men 92.9 (89.8–96.0) 87.0 (82.7–91.2) 77.8 (66.2–89.4)
Women 87.4 (84.5–90.2) 79.7 (75.1–84.2) 80.8 (74.1–87.4)
Republic of 
Moldova
Blood pressure not measured
Men 12.5 (8.9–16.1) 10.9 (7.9–13.9) 6.8 (3.0–10.7)
Women 7.2 (5.1–9.3) 5.5 (3.7–7.2) 4.2 (2.1–6.3)
Blood glucose not measured
Men 53.1 (47.7–58.5) 41.6 (36.5–46.7) 35.5 (28.7–42.3)
Women 39.2 (35.2–43.3) 31.2 (26.5–35.8) 31.9 (26.4–37.4)
Cholesterol not measured
Men 70.4 (65.2–75.7) 62.2 (57.2–67.1) 53.5 (46.9–60.2)
Women 63.7 (59.7–67.6) 52.2 (47.9–56.4) 48.5 (43.3–53.8)
Turkey
Blood pressure not measured
Men 14.0 (10.5–17.6) 18.9 (15.9–21.9) 10.3 (6.7–13.9)
Women 6.8 (5.5–8.2) 16.5 (13.4–19.7) 7.6 (4.3–10.9)
Blood glucose not measured
Men 36.1 (31.8–40.3) 45.6 (41.8–49.4) 27.2 (22.2–32.2)
Women 25.5 (23.1–28.0) 37.3 (33.3–41.3) 23.3 (17.6–28.9)
Cholesterol not measured
Men 47.3 (42.9–51.8) 55.4 (51.6–59.2) 38.8 (32.7–45.0)
Women 36.7 (34.1–39.3) 48.1 (44.1–52.1) 31.9 (25.5–38.3)
Ukraine
Blood pressure not measured
Men 10.5 (2.0–19.0) 11.2 (8.1–14.4) 6.9 (2.7–11.1)
Women 9.3 (2.8–15.8) 7.5 (5.0–10.0) 5.5 (3.3–7.8)
Blood glucose not measured
Men 34.2 (20.5–47.9) 32.8 (27.6–38.1) 23.0 (14.0–32.1)
Women 28.2 (18.0–38.4) 28.2 (24.0–32.4) 19.1 (14.8–23.4)
Cholesterol not measured
Men 75.2 (63.5–87.0) 68.6 (63.6–73.5) 64.7 (51.6–77.8)
Women 62.9 (48.9–76.9) 60.1 (55.9–64.2) 59.8 (54.0–65.5)
Uzbekistan
Blood pressure not measured
Men 62.5 (45.2–79.8) 52.3 (46.2–58.4) 33.9 (23.2–44.6)
Women 51.6 (42.2–60.9) 39.9 (35.3–44.5) 43.1 (33.9–52.3)
Blood glucose not measured
Men 77.9 (62.1–93.6) 81.2 (77.9–84.6) 69.0 (59.3–78.7)
Women 77.7 (72.0–83.5) 70.8 (67.0–74.5) 66.3 (57.9–74.6)
Cholesterol not measured
Men 95.0 (90.6–99.5) 92.0 (89.8–94.2) 82.8 (75.7–89.8)
Women 93.1 (89.6–96.6) 89.6 (87.2–92.0) 87.9 (84.5–91.3)
 CI: confidence interval.
Table A1.23. Percentage not measured for risk factors by income level
Country Risk factor measurement
Low
% (CI 95%)
High
% (CI 95%)
Armenia
Blood pressure not measured
Men 41.0 (35.0–47.1) 37.9 (29.6–46.1)
Women 25.1 (21.7–28.6) 20.6 (16.7–24.5)
Blood glucose not measured
Men 76.4 (71.4–81.4) 67.3 (61.7–72.8)
Women 60.6 (57.0–64.3) 49.9 (44.7–55.1)
Cholesterol not measured
Men 81.8 (77.2–86.4) 69.8 (63.1–76.4)
Women 71.5 (68.0–75.0) 59.5 (54.4–64.7)
Kyrgyzstan
Blood pressure not measured
Men 41.1 (32.0–50.1) 38.7 (29.8–47.6)
Women 19.4 (14.1–24.8) 13.5 (9.4–17.7)
Blood glucose not measured
Men 84.0 (79.7–88.3) 76.6 (71.0–82.2)
Women 71.4 (66.2–76.6) 60.7 (54.8–66.6)
Cholesterol not measured
Men 91.6 (88.2–94.9) 84 .0(77.9–90.1)
Women 86.3 (83.0–89.7) 80.8 (77.4–84.2)
Republic of 
Moldova
Blood pressure not measured
Men 12.3 (9.4–15.3) 9.3 (6.2–12.3)
Women 7.0 (5.1–8.9) 4.8 (3.2–6.4)
Blood glucose not measured
Men 48.7 (43.3–54.0) 42.0 (37.4–46.7)
Women 39.9 (35.8–44.0) 29.6 (26.3–32.8)
Cholesterol not measured
Men 65.9 (60.6–71.2) 62.0 (57.3–66.8)
Women 59.4 (55.5–63.4) 53.3 (49.7–56.9)
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Country Risk factor measurement
Low
% (CI 95%)
High
% (CI 95%)
Turkey
Blood pressure not measured
Men 17.7 (14.6–20.7) 10.8 (7.7–13.9)
Women 12.6 (10.4–14.9) 8.9 (4.8–13.0)
Blood glucose not measured
Men 42.1 (38.1–46.0) 29.4 (24.3–34.5)
Women 34.3 (30.9–37.7) 19.2 (14.3–24.0)
Cholesterol not measured
Men 55.1 (51.4–58.7) 39.4 (33.7–45.1)
Women 45.8 (42.5–49.2) 29.7 (24.1–35.2)
Ukraine
Blood pressure not measured
Men 11.0 (6.0–15.9) 6.1 (2.7–9.5)
Women 5.9 (3.6–8.1) 6.8 (2.7–10.8)
Blood glucose not measured
Men 33.7 (23.3–44.0) 26.9 (19.4–34.4)
Women 27.5 (22.7–32.3) 23.5 (16.7–30.2)
Cholesterol not measured
Men 71.0 (62.1–79.8) 63.7 (55.6–71.8)
Women 59.6 (54.8–64.4) 57.1 (50.2–64.0)
 CI: confidence interval.
Table A1.24. Percentage not measured for risk factors by employment status
Country Risk factor
Employed
% (CI 95%)
Unemployed or not in the 
labour force % (CI 95%)
Belarus
Blood pressure not measured
Men 0.9 (0.4–1.5) 5.4 (0.5–10.3)
Women 0.7 (0.2–1.2) 3.3 (0.0–8.5)
Blood glucose not measured
Men 10.8 (8.1–13.4) 19.3 (9.2–29.4)
Women 9.7 (7.5–12.0) 7.6 (0.0–16.1)
Cholesterol not measured
Men 21.9 (18.5–25.3) 25.1 (13.9–36.4)
Women 20.0 (16.9–23.0) 7.1 (0.0–15.4)
Georgia
Blood pressure not measured
Men 28.2 (23.6–32.9) 32.1 (27.2–37.1)
Women 15.5 (11.8–19.1) 15.4 (13.3–17.5)
Blood glucose not measured
Men 68.8 (64.2–73.5) 68.5 (64.2–72.8)
Women 56.4 (52.2–60.7) 56.7 (53.9–59.6)
Cholesterol not measured
Men 84.2 (80.9–87.5) 88.2 (85.2–91.1)
Women 80.1 (77.1–83.1) 83.3 (81.1–85.5)
Republic of 
Moldova
Blood pressure not measured
Men 9.9 (7.1–12.8) 12.9 (7.7–18.2)
Women 4.7 (3.2–6.3) 6.9 (2.6–11.1)
Blood glucose not measured
Men 42.6 (38.2–47.1) 56.4 (47.6–65.1)
Women 26.7 (23.3–30.1) 43.8 (35.1–52.5)
Cholesterol not measured
Men 61.0 (56.4–65.6) 72.9 (65.2–80.5)
Women 49.6 (45.7–53.5) 67.7 (58.9–76.4)
Ukraine
Blood pressure not measured
Men 8.5 (5.6–11.3) 12.9 (8.3–17.6)
Women 6.5 (4.2–8.8) 7.6 (5.0–10.1)
Blood glucose not measured
Men 26.7 (20.3–33.1) 35.2 (28.9–41.6)
Women 23.0 (18.9–27.0) 27.8 (23.4–32.3)
Cholesterol not measured
Men 68.7 (61.6–75.7) 65.4 (59.0–71.8)
Women 59.8 (55.1–64.5) 60.9 (56.6–65.2)
 CI: confidence interval.
Table A1.25. Percentages not measured for risk factors by a health-care professional in Georgia
Risk factor measurement 
– STEPS 
Men
% (CI 95%)
Women 
% (CI 95%)
2010 2016 2010 2016
Blood pressure not measured 37.4 (32.8–41.9) 30.1 (26.9–33.3) 23.3 (20.4–26.3) 15.4 (13.6–17.3)
Blood glucose not measured 81.3 (78.7–84.0) 68.7 (65.6–71.7) 72.8 (70.8–74.7) 56.7 (54.2–59.1)
Risk factor measurement – 
migrant health survey
Men
% (CI 95%)
Women 
% (CI 95%)
Blood pressure not measured 32.7 (25.2–40.2) 16.2 (12.5–20.0)
Blood glucose not measured 75.0 (70.3–79.7) 63.4 (58.9–67.9)
 CI: confidence interval.
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Table A1.26. Percentage not measured for risk factors by marital status
Country Risk factor
Currently living  
without a partner
% (CI 95%)
Currently living  
with a partner
% (CI 95%)
Belarus
Blood pressure not measured
Men 3.9 (2.2–5.6) 1.1 (0.5–1.6)
Women 1.8 (0.6–3.1) 0.4 (0.0–0.8)
Blood glucose not measured
Men 15.7 (11.8–19.5) 11.3 (8.5–14.0)
Women 10.2 (7.6–12.8) 9.4 (7.0–11.8)
Cholesterol not measured
Men 29.2 (24.0–34.4) 19.9 (16.6–23.2)
Women 18.5 (15.0–22.1) 19.5 (16.4–22.6)
Uzbekistan
Blood pressure not measured
Men 56.1 (42.7–69.4) 48.1 (42.7–53.4)
Women 51.9 (42.6–61.1) 37.9 (33.6–42.3)
Blood glucose not measured
Men 90.9 (85.8–96.1) 73.5 (69.2–77.8)
Women 81.8 (77.2–86.4) 67.7 (63.8–71.6)
Cholesterol not measured
Men 93.9 (89.5–98.4) 89.8 (87.3–92.3)
Women 93.0 (90.3–95.7) 88.9 (86.4–91.4)
 CI: confidence interval.
Table A1.27. Percentages of lifestyle advice given for related risk factors
Country Risk factor
 
Advice given
% (CI 95%)
Prevalence of related 
risk factor
% (CI 95%)
Armenia
Tobacco
Men 17.4 (13.7–21.1) 51.5 (47.4–55.6)
Women 1.7 (1.0–2.5) 1.8 (1.1–2.5)
Diet – added salt
Men 13.9 (10.5–17.2) 40.3 (36.1–44.4)
Women 14.7 (12.4–16.9) 30.1 (27.1–33.1)
Diet – fruit and vegetables
Men 18.0 (14.0–21.9) 78.4 (74.3–82.4) 
Women 25.3 (22.4–28.1) 73.5 (70.4–76.6)
Physical activity
Men 15.2 (11.5–18.9) 22.0 (18.0–26.1)
Women 15.7 (13.1–18.3) 20.4(17.3–23.5)
Body weight
Men 10.6 (7.7–13.5) 45.4 (40.6–50.2)
14.8 (12.4–17.3) 50.1 (46.7–53.5)
Belarus
Tobacco
Men 43.6 (40.0–47.1) 48.4 (42.8–48.6)
Women 20.7 (17.6–23.9) 12.6 (8.9–11.6)
Diet – added salt
Men 42.3 (38.5–46.2) 35.8 (31.9–39.7)
Women 41.7 (37.8–45.6) 28.0 (24.5–31.4)
Diet – fruit and vegetables
Men 38.9 (34.5–43.3) 77.9 (74.3–81.5)
Women 42.7 (38.8–46.7) 68.4 (64.7–72.0)
Physical activity
Men 38.6 (34.4–42.7) 12.8 (10.7–14.9)
Women 43.2 (39.5–46.9) 13.5 (11.5–15.5)
Body weight
Men 38.2 (34.1–42.3) 61.5 (58.7–64.2)
46.8 (43.1–50.5) 60.0 (57.3–62.4)
Georgia
Tobacco
Men 28.8 (25.6–32.0) 57.0 (53.6–60.3)
Women 5.4 (4.0–6.8) 7.0 (5.8–8.2)
Diet – added salt
Men 20.9 (18.2–23.5) 33.4 (29.4–37.3)
Women 17.4 (15.5–19.3) 20.6 (18.6–22.7)
Diet – fruit and vegetables
Men 21.0 (18.2–23.8) 63.8 (59.6–67.9)
Women 20.6 (18.3–22.9) 62.4 (59.5–65.3)
Physical activity
Men 23.1 (20.1–26.1) 16.2 (13.6–18.9)
Women 21.8 (19.6–24.0) 18.4 (16.3–20.4)
Body weight
Men 21.4 (18.6–24.3) 65.5 (61.4–69.7)
Women 20.8 (18.7–22.9) 63.8 (61.4–66.3)
Kyrgyzstan
Tobacco
Men 44.5 (38.3–50.7) 48.2 (43.6–52.8)
Women 27.2 (22.5–32.0) 2.7 (1.7–3.7)
Diet – added salt
Men 39.4 (33.2–45.6) 20.4 (14.7–26.1)
Women 54.7 (49.1–60.3) 15.6 (11.9–19.4)
Diet – fruit and vegetables
Men 43.9 (39.1–48.8) 76.7 (71.3–82.2)
Women 57.9 (53.1–62.7) 71.1 (65.6–76.7)
Physical activity
Men 38.7 (33.4–43.9) 8.9 (6.4–11.3)
Women 43.1 (37.6–48.5) 14.1 (11.7–16.5)
Body weight
Men 32.5 (26.9–38.2) 49.4 (42.4–56.5)
Women 40.1 (35.6–44.7) 63.5 (60.2–66.8)
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Table A1.27 contd
Country Risk factor
 
Advice given
% (CI 95%)
Prevalence of related 
risk factor
% (CI 95%)
Republic of 
Moldova
Tobacco
Men 50.4 (46.5–54.3) 43.6 (37.5–43.7)
Women 32.1 (28.1–36.1) 5.6 (4.5–6.7)
Diet – added salt
Men 54.7 (50.4–59.0) 28.0 (24.7–31.3)
Women 61.2 (57.6–64.9) 20.3 (18.1–22.5)
Diet – fruit and vegetables
Men 59.2 (55.2–63.2) 65.8 (62.1–69.5)
Women 66.4 (63.3–69.6) 67.5 (64.5–70.6)
Physical activity
Men 51.6 (47.4–55.9) 10.7 (8.5–12.9)
Women 57.2 (53.4–61.1) 9.4 (7.7–11.1)
Body weight
Men 48.6 (44.1–53.1) 56.0 (52.7–59.4)
56.0 (52.1–59.9) 55.9 (53.1–58.7)
Turkey
Tobacco
Men 18.6 (16.3–20.8) 43.4 (40.8–46.0)
Women 11.1 (9.6–12.6) 19.7 (17.6–21.8)
Diet – added salt
Men 20.8 (18.5–23.1) 29.3 (26.7–31.9)
Women 23.9 (21.9–25.9) 26.8 (24.6–29.0)
Diet – fruit and vegetables
Men 19.3 (17.0–21.7) 87.8 (85.8–89.8)
Women 20.4 (18.3–22.4) 87.9 (86.3–89.5)
Physical activity
Men 20.3 (18.0–22.5) 33.1 (30.5–35.6)
Women 26.2 (24.1–28.3) 53.9 (51.6–56.3)
Body weight
Men 18.9 (16.6–21.2) 62.8 (60.2–65.4)
25.4 (23.2–27.5) 66.0 (63.7–68.4)
Ukraine
Tobacco
Men 37.5 (29.6–45.3) 50.3 (43.6–57.1)
Women 19.3 (15.1–23.5) 16.7 (14.3–19.1)
Diet – added salt
Men 30.2 (22.0–38.4) 53.0 (46.3–59.7)
Women 26.2 (22.3–30.2) 36.5 (32.5–40.4)
Diet – fruit and vegetables
Men 39.1 (31.3–46.9) 73.2 (67.9–78.6)
Women 39.4 (34.4–44.3) 59.4 (55.3–63.6)
Physical activity
Men 32.2 (25.9–38.5) 9.1 (6.6–11.7)
Women 32.9 (28.3–37.4) 10.8 (8.3–13.3)
Body weight
Men 30.1 (23.8–36.6) 58.0 (50.4–65.5)
Women 36.6 (32.1–41.1) 60.2 (57.0–63.4)
Uzbekistan
Tobacco
Men 38.9 (26.6–51.2) 18.8 (15.3–22.2)
Women 15.5 (9.3–21.6) 0.5 (0.2–0.9)
Diet – added salt
Men 49.0 (38.5–59.5) 34.4 (29.2–39.6)
Women 39.4 (30.1–48.7) 38.7 (34.6–42.7)
Diet – fruit and vegetables
Men 66.6 (56.1–77.0) 14.7 (11.4–18.1)
Women 68.0 (60.5–75.6) 17.2 (14.3–20.1)
Physical activity
Men 63.6 (54.8–72.5) 20.5 (16.7–24.4)
Women 58.6 (51.7–65.4) 31.2 (27.2–35.3)
Body weight
Men 58.7 (49.7–67.7) 55.6 (50.8–60.4)
Women 51.0 (42.7–59.4) 57.3 (53.8–60.8)
 CI: confidence interval.
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